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Abstract 
Background and Objectives There is evidence that paediatric brain tumour survivors 
show impaired memory when compared to normative data (Robinson et al., 2013), 
however differences may be due to confounding factors. The current review assessed 
memory outcomes in brain tumour survivors relative to matched controls.   
Data Sources PsycINFO, CINAHL, MEDLINE, EMBASE, and Web of Science.  
Study Eligibility Quantitative articles comparing memory (assessed with standardised 
measures) in paediatric brain tumour survivors and healthy or non-CNS cancer controls.  
Study appraisal Methodological quality of studies was rated using a modified version of 
the SIGN Cohort Study Critical Appraisal Checklist.  
Results High quality studies provided evidence of visual and verbal long-term memory 
impairment in survivors compared to healthy controls, and visual long-term memory 
impairment relative to non-CNS cancer controls. There was evidence that survivors have 
impaired verbal working memory compared to healthy but not non-CNS cancer controls, 
however most studies failed to control for IQ, therefore differences may reflect underlying 
cognitive deficits. There was insufficient robust evidence to determine whether visual 
working memory is impaired in survivors compared to controls.  
Limitations The tool used to critically appraise the studies did not differentiate between 
the studies well and some degree of subjectivity was used. A second rater minimised the 
risk of bias.   
Conclusions Further high quality research is required to understand the long-term effects 
of brain tumours on memory. The results of the current review, however, can be used to 
better support paediatric brain tumour survivors in educational settings and increasing 
early assessment and recognition of memory impairments in school and clinical settings.   
Keywords paediatric brain tumour, controlled study, memory. 
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Introduction 
Central Nervous System (CNS) tumours are among the most common paediatric cancers in 
the UK (Stiller, 2007). Improvements in treatments such as chemotherapy and radiotherapy 
have led to an increase in survival rates among this population, but there is significant 
evidence that survivors experience a range of long-term cognitive deficits (Robinson et al., 
2010). 
 
Most of the research exploring cognitive outcomes after brain tumours is observational and 
retrospective (George et al., 2003). Some studies prospectively assess cognitive outcomes 
in brain tumour survivors at one, or numerous, time points post-treatment. Previous 
reviews suggest brain tumour survivors have deficits in overall cognitive functioning, 
academic achievement, attention, memory, and language (Robinson et al., 2010; De Ruiter, 
Van Mourik, Schouten-Van Meeteren, Grootenhuis, & Oosterlaan, 2013) and that general 
cognitive ability significantly reduces over time (Mulhern et al., 2004). Younger age at 
treatment, cranial irradiation therapy, tumour size and severity, and treatment 
complications such as hydrocephalus have also been found to impact negatively on 
cognitive outcomes (Shortman et al., 2014).  
 
Most research on memory compares outcomes in paediatric brain tumour (PBT) survivors 
to normative data. A recent meta-analysis reported the magnitude of impairment in 
paediatric and young adult survivors of PBT of the posterior fossa relative to norms using 
Hedges g (which represents the number of standard deviations the PBT survivors mean 
differed from the mean of normative samples on cognitive measures; Robinson et al., 
2013). They estimated verbal and visual memory as -1.12 and -0.68, respectively, 
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suggesting both are significantly affected in relative to norms. Normative samples fail to 
match patient samples for age, educational level or gender, and often for ethnic or cultural 
background. It is unclear whether impairments in survivors are due to treatment and 
tumour factors, or demographics. Studies comparing survivors with appropriately matched 
controls allow stronger conclusions to be made regarding cognitive deficits. Memory 
deficits in young people have significant implications for future learning and academic 
achievement, as well as quality of life (Waber et al., 2006; Ullrich & Embry, 2012). 
 
A systematic review of controlled studies comparing cognitive function in adult survivors 
has been conducted (Gehrke, Baisley, Sonck, Wronski, & Feuerstein, 2013), but one in 
paediatric survivors has not. The current systematic review aims to critically examine 
studies comparing memory outcomes in PBT survivors with an appropriately matched 
control group. The literature on brain tumour survivors includes a range of tumour and 
treatment factors, which are all included in the review, in line with previous meta-analyses 
(Robinson et al., 2010; Gehrke, et al., 2013). 
 
Aim 
The aim is to systematically review the literature and compare memory in PBT survivors 
with appropriately matched controls.  
 
Research Questions 
Are Working Memory (WM) and Long-Term Memory (LTM) functions significantly 
impaired in PBT survivors compared to healthy or non-CNS cancer controls? 
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Methods 
Search Protocol 
When considering search terms, a PICOS Model, outlined in the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009), 
was utilised. Participants were paediatric brain tumour survivors; Intervention related to 
the diagnosis of brain tumour; Comparison related to an appropriate control group (healthy 
or non-CNS cancer controls); Outcome related to memory; Study Design was comparative. 
Once search terms were allocated to each factor, Pubreminer was utilised to explore 
alternative search terms that may be used in articles. Previous systematic reviews (Gehrke 
et al., 2013; Robinson et al., 2010) were used for comparison.  
 
The following electronic databases were searched:  PsycINFO (EBSCO), CINAHL 
(EBSCO), MEDLINE (OVID), EMBASE (OVID), and Web of Science. These were 
chosen because they are routinely used in reviews in neuropsychology (Gehrke et al., 
2013; Robinson et al., 2010). The search took place on the 31st January 2015 for all 
databases. An initial search included an exhaustive list of paediatric brain tumour 
diagnoses and neurocognitive processes, but this resulted in a number of irrelevant articles. 
Only the main six brain tumour diagnoses and memory-related terms were included. The 
search time frame covered all available years indexed by each database until the date the 
search was performed.  
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Final Search 
1.  intracranial OR brain OR cerebr* OR cerebell* OR cranial 
AND 
2. tum?r OR neoplasm* OR cancer*  
OR 
3. astrocyt* OR glioma* OR glioblastoma OR ependymoma OR medulloblastoma* OR 
craniopharyngioma*   
AND  
4. Paediatric OR child* 
AND 
5. memory OR recall OR retention OR long-term memory OR short-term memory OR 
working memory 
 
Search Results: 
PsychINFO (EBSCO): 161 
CINAHL (EBSCO): 90 
MEDLINE (OVID): 436 
EMBASE (OVID): 908 
Web of Science: 706 (limited to English articles) 
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Inclusion and Exclusion Criteria 
Figure 1 provides a flowchart summary of inclusion and exclusion criteria and the process 
of article selection in line with the PRISMA guidelines (Liberati et al., 2009). 
Inclusion Criteria 
 Articles comparing memory in PBT survivors and healthy or non-CNS cancer 
controls 
 Articles assessing memory using standardised and valid tools 
 Quantitative articles with a cross-sectional or longitudinal design 
 All brain tumour diagnoses, tumour grades, locations, or treatment modalities 
 Articles published in a peer-reviewed journal, in English 
 
Exclusion Criteria 
 Articles that included brain tumour survivors in the control group 
 Articles that did not include a control group and compared PBT survivors to 
normative data  
 Articles that included only samples of Acute Lymphoblastic Leukaemia 
 Articles that included participants who had received cognitive rehabilitation 
 Memory assessments that are not standardised or validated with young people 
 Articles including only the assessment of facial or episodic memory 
 Samples receiving ongoing treatment with radiotherapy or chemotherapy for a 
brain tumour or a secondary cancer 
 Articles including only adult samples, in which all participants are above the age of 
18 
 Dissertations, theses, conference abstracts and review articles  
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Figure 1. PRISMA Flow Chart  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exact duplicates removed 
n= 971 
Articles screened by title 
n=1,330 
Excluded on title alone 
n= 771 
Articles screened by abstract  
n=559 
Abstracts not relevant = 126 
Reviews /systematic reviews 
=52  
 
 
Articles assessed for eligibility 
based on abstract  
n= 381 
Articles identified by electronic 
database search 
n= 2,301 
Adult participants = 49 
No control group = 247 
Acute Lymphoblastic Leukaemia 
sample = 29 
Not full texts = 21 
 
Full text articles assessed for 
eligibility  
n= 35 Adult participants = 2 
No control group = 8 
Acute Lymphoblastic 
Leukaemia sample =2 
Facial or episodic memory only 
=3  
Memory assessment not 
standardised =6 
Participants receiving ongoing 
treatment =2  
 
 
Articles selected for inclusion 
in systematic review 
n=12 
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Results 
Study Characteristics  
The systematic search resulted in twelve articles which assessed memory in PBT survivors 
against a control group that was either healthy or had survived a non-CNS cancer. Three 
studies were produced by the same research group (Horska et al., 2010; Horska et al., 
2014; Redmond et al., 2013) and there was an overlap in their PBT survivor samples. The 
Redmond et al. (2013) study included most of the participants in the Horska et al. (2010; 
2014) studies, therefore results for the Redmond et al. (2013) will be reported. Two further 
studies were produced by similar research groups (Law et al., 2011; Mabbott, Penkman, 
Witol, Strother, & Bouffet, 2008) and there the samples of PBT survivors likely 
overlapped. The studies utilised different memory assessments and different control 
groups, therefore each contributed novel information and were both included in the review.  
Table 1 summarises the demographic and clinical characteristics of tumour and control 
samples the ten studies included in the review. In seven studies, the primary aim was to 
assess general cognitive functioning, including memory, in groups; one study exclusively 
assessed memory (Conklin et al., 2012); two studies explored the degree to which changes 
in brain structure in PBT survivors were associated with cognitive outcomes (Law et al., 
2011; Robinson et al., 2014) 
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Table 1. Demographic and clinical characteristics of participants in each of the articles 
 
Study Study 
design 
Tumour 
Sample 
Gender 
 
Mean 
age in 
years 
Mean age 
diagnosis 
/treatment 
Diagnoses in 
Clinical Group 
Location of 
tumour 
Surgical 
resection 
 
Treatment in 
clinical group 
Control 
Group(s) 
CT RT 
Conklin et 
al. (2012) 
Cross 
Section 
n=50 M=25 
F=25 
13.18 
(±0.41) 
6.38  
(± 0.37) 
Ependymoma (n=22) 
low grade glioma 
(n=12) 
craniopharyngioma 
(n=16) 
Infratentorial 
(n=22) 
Supratnetorial 
(n=28) 
Biopsy/ STR 
n=25 
NTR/GTR 
n=25 
n=6 
 
 
CRT 
n=50 
Healthy 
Siblings 
(n=40) 
Non-CNS 
Cancer 
(n=40) 
Garcia-
Perez et al. 
(1994) 
Cross 
Section 
n=25  Not 
Specified 
11.76 
(range 
6-25) 
 
8.04  Medulloblastoma 
(n=7) 
Oligodendroglioma 
(n=1) 
Astrocytoma (n=5) 
Glioma (n=7) 
Pineal Tumour (n=1) 
Ependymoma (n=4) 
Anterior fossa 
(n=4) 
Middle fossa 
(n=7) 
Posterior fossa 
(n=14) 
Not 
specified 
n=25 Involved 
RT 
(n=25) 
 
WBR 
(n=14) 
Chronic 
disease 
(n=25)  
 
Non-CNS 
Cancer 
(n=25) 
Law et al. 
(2011)  
Cross 
Section 
n=29 
 
M=16 
F=13 
11.36 
(±3.74) 
7.63  
(SD 3.20) 
Ependymoma (n=5) 
Medulloblastoma 
(n=23) 
Germinoma (n=1) 
 
Posterior Fossa 
(n=29) 
Biopsy 
(n=7) 
50-95% 
resection 
(n=6) 
Over 95% 
resection 
(n=16) 
n=23 Cranio-
spinal 
(n=23) 
 
Focal 
(n=6) 
Healthy 
Children 
(n=26) 
 
Surgery 
only BT 
(n=12) 
Mabbott et 
al. (2008) 
Cross 
Section 
n=32 M=18 
F=14 
11.44 
(SD 
2.99) 
6.85 
(SD 2.66) 
Medulloblastoma 
(n=22) 
Ependymoma (n=5) 
Glioma (n=4) 
No Information (n=1) 
Posterior Fossa 
(n=32) 
50-95% 
resection 
(n=8) 
Over 95% 
resection 
(n=24) 
n=21 Cranio-
spinal 
(n=23) 
 
Focal 
(n=9) 
Non-CNS 
Survivors 
(n=10) 
Surgery 
only BT 
(n=30) 
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Study Study 
design 
Tumour 
Sample 
Gender 
 
Mean 
age in 
years 
Mean age 
diagnosis/ 
treatment 
Diagnoses in 
Clinical Group 
Location of 
tumour 
Surgical 
resection 
 
Treatment in 
clinical group 
Control 
Group(s) 
CT RT 
Ozyurt et 
al. (2014) 
Cross 
Section 
n=15 M=9 
F=6 
19.38  11.7 Craniopharyngioma 
n=15 n  
Intrasellar (n=5) 
Extrasellar 
(n=10) 
Complete 
(n=7) 
Incomplete 
(n=8) 
 GK 
(n=1)  
 
EPT 
(n=4) 
Healthy  
controls 
(n=24) 
Quintero-
Gallego et 
al. (2006) 
 
Cross 
Section 
n=18 M=6 
F=12 
12.16 8.08  
(SD 3.19) 
Astrocytoma (n=11) 
Medulloblastoma 
(n=7) 
 
Posterior fossa 
(n= 18) 
Not 
specified  
n=7 
 
n=7 Healthy 
controls 
(n=12) 
Redmond 
et al. (2013) 
Longitud
inal  
 
Total 
n=19 
(15m FU 
n=14) 
(27m FU 
n=10) 
 
 
M=12 
F=7 
12.11 11.8  
(range 1.1-
18.6) 
Glioma (n=4) 
Medulloblastoma/ 
PNET (n=5) 
Germinoma (n=3) 
Leukemia (n=2) 
Nongerminoma germ 
cell tumour (n=2) 
Pineoblastoma (n=1) 
Craniopharyngioma 
(n=1) 
Ependymoma (n=1) 
Infratentorial 
(n=5) 
Supratentorial 
(n=14) 
 
 
Not 
specified 
n=8 Cranio-
spinal 
(n=8) 
 
WBR 
(n=3) 
 
IMRT 
(n=8) 
Healthy 
controls 
(n=55) 
 
(27m FU 
n=37) 
Riva et al. 
(2002) 
Cross 
Section 
n=21 
 
 
M=11 
F=10 
Median 
=12:9 
3-10 yrs 
(n=12) 
>10 yrs 
(n=9) 
Medulloblastoma (n= 
21) 
Cerebellum 
(n=21) 
Vermis (n=8) 
Vermis /Fourth 
Ventricle (n=9) 
Lateral Recesses 
(n=1) 
Right Hem. 
(n=3) 
 
Incomplete 
resection 
(n=8) 
 
Complete 
resection 
(n=13) 
n=21 
 
ITM 
(n=11) 
 
No 
ITM 
(n=10) 
Cranio-
spinal 
(n=21) 
Siblings 
and 
cousins 
controls 
(n=20) 
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Study Study 
design 
Tumour 
Sample 
Gender 
 
Mean 
age in 
years 
Mean age 
diagnosis/ 
treatment 
Diagnoses in 
Clinical Group 
Location of 
tumour 
Surgical 
resection 
 
Treatment in 
clinical group 
Control 
Group(s) 
CT RT 
Robinson et 
al. (2014) 
Cross 
Section 
n=17 M=7 
F=10 
12.60 
(SD 
2.48) 
6.94 
(SD 2.41) 
PA (n=9) 
Medulloblastoma 
(n=4) 
Dysembryoplastic 
neuroepithelial 
tumour (n=3) 
Craniopharyngioma 
(n=1) 
Posterior Fossa 
(n=13) 
Parietal Lobe 
(n=2) 
Temporal Lobe 
(n=1) 
Pituitary Gland 
(n=1) 
n=17 n=5 n=5 Healthy 
control 
group 
(n=15) 
Shortman 
et al. (2014) 
Longidtu
dinal  
 
 
12m FU 
n=25  
M=14 
F=15 
12m 
FU: 
Mean  
age 
11.26  
Median age 
9.4 
 
Low grade 
astrocytoma (n=14) 
High grade 
astrocytoma (n=3) 
Craniopharyngioma 
(n=2) 
Germ cell tumour 
(n=3) 
Ependymoma (n=2) 
PNET (n=4) 
Meningioma (n=1) 
Supratentorial 
(n=15) 
Infratentorial 
(n=14) 
No 
information 
n=7 n=29 Best 
friends 
control 
group 
(n=23 at 
12m FU) 
Key 
ALL= Acute Lymphoblastic Leukaemia 
BT= Brain Tumour 
CNS= Central Nervous System 
CRT= Conformal Radiation Therapy 
CT= Chemotherapy 
EPT= External Photon Therapy 
F=Female 
FU= Follow-up 
GK= Gamma Knife 
GTR= Gross Total Resection 
ITM= Intrathecal Methotrexate 
IMRT= Intensity-Modulated Radiotherapy 
M=Male 
MT= Medial Temporal 
NTR= Near Total Resection 
PA= Pilocytic Astrocytoma 
PNET= Primitive Neuroectodermal Tumour  
RT= Radiotherapy 
SD= Standard Deviation 
STR= Sub-Total Resection  
WBR= Whole Brain Radiation
 
 
 
 
13 
 
 
Methodological Quality and Risk of Bias 
Quality was evaluated using an adapted version of the SIGN Cohort Study Checklist, 
(Appendix 1.2), commonly used to assess methodological quality in articles. The checklist 
includes 17 items related to selection, performance, detection and attrition bias, and an 
overall quality rating. Exposure status related to having had a brain tumour, and outcome 
related to memory.  
 
The articles were appraised according to the SIGN checklist and overall quality ratings 
assigned. A ‘High Quality’ rating was given to studies with a robust design, minimising the 
risk of bias and controlling for the majority of confounding factors, specifically either IQ 
or psychological factors had be matched between groups to receive this rating; an 
‘Acceptable’ rating given to studies that minimised some bias, but included some design 
limitations which would increase the risk of bias, such as not matching groups for IQ or 
psychological factors; an ‘Unacceptable’ rating, suggestive of a high likelihood of bias, 
was not given to any articles under review. Eight articles were further rated by an 
independent rater. Percentage agreement between ratings was 87.5 percent. Items rated 
differently were discussed and given an agreed rating. The overall quality rating for each 
study is shown in Tables 2, 3 and 4, and a breakdown of each item is shown in Appendix 
1.3.  
 
Definition of Memory Terms 
The literature includes a number of memory theories and the terms ‘short-term memory’, 
‘working memory’ and ‘long-term memory’ are not used consistently. Andrade (2001) 
believes the most widely used memory model is that of Baddeley and Hitch (1974), which 
suggests memory is made up of two systems, working memory (a multi-component system 
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that includes the temporary storage and manipulation of information) and long-term 
memory (a long-term store that has a very large capacity).  
 
Some articles refer to the temporary storage of information within the working memory 
system as ‘short-term memory’ and only use ‘working memory’ to refer to the process of 
temporarily holding information whilst simultaneously performing cognitive processes on 
it (Daneman and Carpenter, 1980). Aben, Stapert and Blokland (2012) acknowledge that 
both terms are often used interchangeably in the literature. Recent research has found that 
performance in assessments which measure only short-term storage (simple serial recall 
tasks) do not correlate as highly with intellectual functioning as performance in those that 
require both storage and processing (Conway et al., 2005 and Engle, Tuholski, Laughlin & 
Conway, 1999), suggesting different memory functions. Another explanation for this 
finding, suggested by Cowan (2008), proposes that working memory includes an 
attentional mechanism and an executive function which affects manipulation. This may 
account for the variability in the relationship between working memory and cognitive 
ability. Cowan (2008) suggests the attentional aspect is akin to the episodic buffer, a 
mechanism within working memory that was added by Baddeley to his original model in 
2000.  
 
Given the variation in the literature, within the current review, ‘working memory’ will be 
used to refer to both the temporary storage and the manipulation of information. In line 
with current findings, working memory tasks that include the manipulation of temporarily 
stored information, such as backward digit span tasks, will be reported separately to those 
that only require only the temporary storage of information, such as forwards digit span 
tasks. Most results collate performance in such tasks, however, giving a standardised 
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working memory score, such as in the Digit Span subtest of Wechsler Scales, which 
therefore include both the storage and manipulation of information.  
Long-term memory is generally agreed within the literature to refer to information that is 
rehearsed for longer than a few seconds and enters the long-term store. If information is 
repeated until learned, it has therefore entered the long-term store. Some memory 
assessments refer to the immediate recall of learned items as ‘short-term memory’ and 
delayed recall (usually after half an hour) as ‘long-term memory’, however both require 
retrieval from long-term store. Within the current review, measures that include learning 
trials will be categorised as long-term memory measures, however immediate and delayed 
recall will be discussed separately.  
 
Data Extraction and Analysis 
In order to answer the question of whether memory is significantly impaired in PBT 
survivors relative to controls, relevant data regarding memory assessments and results were 
extracted and summarised in Tables 2, 3 and 4. Authors of articles that did not report 
memory results were contacted via email and asked to provide this data (indicated with an 
asterisk in Tables 2, 3 and 4). As non-CNS cancer controls share additional cancer and 
treatment-related factors with PBTS that healthy controls do not, results were categorised 
by control group. Data on further variables matched across groups were extracted. Effect 
sizes of group differences were calculated for the parametric data using Cohen’s d equation 
(Cohen, 1977). There was insufficient information to calculate non-parametric effect sizes. 
Negative effect sizes indicate the PBT group performed worse than the controls, positive 
indicate the PBT group performed better. Because outcome measures and designs varied 
across studies, the results, their limitations and applicability have been described in a 
narrative synthesis rather than a meta-analysis.  
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Table 2. Working memory in paediatric brain tumour survivors compared to healthy controls. 
 
Study Outcome 
Measure 
and 
Subtest 
Memory 
Function 
 
Outcome 
Score 
Group 
Analysis 
Mean Result 
Clinical group 
(SD) 
Mean Result 
Control group 
(SD) 
Statistical 
Test and 
significance 
Effect 
Size 
Variables 
Matched 
Across Groups 
Quality 
Rating  
 
Robinson et 
al. (2014) * 
WISC 
DS/ 
LNS 
Verbal 
WM 
Standardised 
WM Index  
(M 100/ SD 15) 
 90.94 (12.47) 101.93 (8.92) t-test 
(p=0.008) 
 
d= -1.01 Age, gender, 
SES, 
psychological 
problems 
IQ not matched 
High quality 
Riva et al. 
(2002) 
WISC 
DS  
 
 
 
 
 
Verbal 
WM 
 
 
 
Standardised 
 
Clinical 
subgroups 
3-10 at diag. 
>10 at diag. 
 
 
3-10 at diag. 
>10 at diag. 
 
ITM Group 
5.17 (2.4)  
5.6 (2.07) 
 
No ITM Group 
7.33 (3.5)  
7 (0.82) 
 
 
8.83 (2.48) 
10.25 (1.5) 
 
 
8.67 (2.58) 
7.5 (1.73) 
MWU 
 
(p=0.036)  
(p=0.014) 
 
 
Not sig 
Not sig 
IDC 
 
Age, SES and 
family factors 
 
IQ matched on 
all comparisons 
except PBT 
survivors under 
10 who received 
ITM and 
controls under 
10  
High quality 
 
BVRT 
Multiple 
Choice 
Task 
Visual 
WM 
 
Raw scores 
 
 
3-10 at diag. 
>10 at diag. 
 
 
3-10 at diag. 
>10 at diag. 
ITM Group 
8.83 (2.79) 
12.3 (3.11) 
 
No ITM Group 
10.42 (2.62) 
12.75 (0.5) 
 
13.1 (1.34) 
13.88 (1.32) 
 
 
13.25 (1.94) 
13.25 (0.5) 
MWU 
(p=0.016) 
Not sig 
 
 
Not sig 
Not sig 
IDC 
 
 
Law et al. 
(2011)  
WISC 
DS/ LNS  
Verbal 
WM 
Standardised 
WM Index 
(M 100/SD 15) 
Clinical 
subgroups 
RT 
SO 
 
 
88.37 (14.93) 
98.27 (14.85) 
 
 
102.24 (10.13) 
102.24 (10.13) 
ANCOVA 
 
(p=0.04) 
Not sig 
 
 
d= -1.09 
d= -0.31 
Age, gender and 
parental 
education 
IQ not matched 
Acceptable 
Quality 
Conklin et 
al. (2012)*  
WISC/ 
WAIS 
DSB/ DSF 
Verbal 
WM 
 
z-scores   
DSB: -0.1228 
DSF: NR 
 
DSB: 0.5663 
DSF: NR 
ANOVA 
p=0.01 
Not sig 
IDC Family factors, 
age, gender,  
IQ not matched 
Acceptable 
quality 
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Study Outcome 
Measure 
and 
Subtest 
Memory 
Function 
 
Outcome 
Score 
Group 
Analysis 
Mean Result 
Clinical group 
(SD) 
Mean Result 
Control group 
(SD) 
Statistical 
Test and 
significance 
Effect 
Size 
Variables 
Matched 
Across Groups 
Quality 
Rating  
 
Redmond 
et al. (2013) 
* 
SBIS 
BMT 
 
 
WJ 
AWMT 
Visual 
WM 
 
 
Verbal 
WM 
z- score 
 
 
 
Standard 
 
15month FU 
27month FU 
 
15month FU 
27month FU 
 
22.71 (7.18) 
21.4 (6) 
 
Not reported 
 
26.89 (4.94) 
28.03 (4.68) 
 
Not reported 
LME 
Sig 
Sig 
 
Not sig 
Not sig 
 
d= -0.68 
d= -1.23 
 
IDC 
IDC 
Matching of 
controls not 
discussed 
 
Acceptable 
Quality 
Quintero -
Gallego et 
al. (2006) 
CVLT-C 
Learning 
trial 1 
Verbal 
WM 
 
Raw Score 
 
Clinical 
Subgroups 
Medullo-
blastoma 
 
 
6.42 (1.13) 
 
 
7.33 (1.43) 
MANOVA 
 
Not sig 
 
 
d= -0.71 
IQ not 
controlled for 
 
Acceptable 
Quality 
Astrocytoma 7.27 (1.55) 7.33 (1.43) Not sig d= -0.04 
 
Key 
ANOVA= Analysis of Variance 
AWMT= Auditory Working Memory Test  
BMT= Bead Memory Test 
BVRT= Benton Visual Retention Test 
CVLT-C= California Verbal Learning Test Child 
DS= Digit Span 
DSF= Digit Span Forward 
DSB= Digit Span Backward 
 
 
FU= Follow-up 
GLM= General Linear Modelling 
IDC= Insufficient Data to Calculate Effect Size 
ITM= Intrathecal Methotrexate 
LME= Linear Mixed Effect Regression  
LNS= Letter-Number Sequencing 
M= Mean 
MANOVA= Multivariate Analysis of Variance 
MWU= Mann-Whitney U 
 
 
NR= Not reported 
RT= Radiotherapy  
SBIS= Stanford-Binet Intelligence Scale 
SD= Standard Deviation 
SO= Surgery Only 
SES= Socio-Economic Status 
WAIS= Wechsler Adult Intelligence Scale 
WISC= Wechsler Intelligence Scale Children  
WJ= Woodcock Johnson Test of Achievement 
WM = Working Memory
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Table 3. Working memory in paediatric brain tumour survivors compared with non-CNS cancer controls 
 
Study Outcome 
Measure and 
Subtest 
Memory 
Function 
 
Outcome 
Score 
Group Analysis Mean Result 
Clinical group 
(SD) 
Mean Result 
Control 
group 
(SD) 
Statistical 
Test and 
significance 
Effect Size Variables 
Matched 
Across Groups 
Quality 
Rating  
 
Garcia-
Perez et 
al. (1994)  
 
 
 
WISC  
DS 
Verbal 
WM 
Standard 
score 
(M=10, 
SD=3) 
Clinical vs Non-
CNS cancer 
controls 
 
9 (3.27) 
 
10.63 (2.43) 
MWU  
(Not sig) 
 
IDC 
Age, parental 
SES, 
psychological 
impact of 
illness, 
cognitive ability 
High quality 
WISC  
DS 
Verbal 
WM 
Standard 
score 
(M=10, 
SD=3) 
Clinical vs 
chronic disease 
controls 
 
9 (3.27) 
 
10.14 (2.63) 
MWU  
Not sig 
 
IDC 
Mabbott 
et al. 
(2008)  
WJ 
AWMT 
 
WISC/WAIS 
DS 
Verbal 
WM 
 
Verbal 
WM 
Standard 
score 
 
Scaled 
score 
  
101.79 (2.93) 
 
9.29 (0.49) 
 
102.10 (5.16) 
 
8.70 (0.86) 
MANOVA 
Not sig 
 
Not sig 
 
d= -0.07 
 
d= 0.84 
Age, 
psychological 
impact of 
illness, RT dose. 
IQ not matched 
Acceptable 
quality 
WISC/WAIS 
Spatial Span 
Visual 
WM 
Scaled 
score 
 8.84 (0.58) 8.80 (1.02) Not sig d= 0.05 
Conklin 
et al. 
(2012) * 
WISC/WAIS 
DSF 
DSB 
Verbal 
WM 
z-score  DSF: not 
reported 
DSB= 0.1228 
DSF: not 
reported 
DSB= 0.4500 
Not sig 
ANOVA  
(p=0.01) 
IDC Age, family, 
psychological 
impact of 
illness. 
IQ not matched 
Acceptable 
quality 
Key 
DS= Digit Span 
DSB= Digit San Backwards 
DSF= Digit Span Forwards 
IDC= Insufficient Data to Calculate Effect Size 
M= Mean 
MANOVA= Multivariate Analysis of Variance 
MWU= Mann-Whitney U 
RT= Radiotherapy  
SD= Standard Deviation 
SES= Socio-Economic Status 
WAIS= Wechsler Adult Intelligence Scale 
WISC= Wechsler Intelligence Scale Children  
WM= Working Memory
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Table 4. Long-term memory in paediatric brain tumour survivors compared with healthy (current page) and non-CNS cancer controls (next page) 
 
Study Outcome 
Measure 
and 
Subtest 
Memory 
Function 
 
Outcome 
Score 
Group 
Analysis 
Mean Result 
Clinical 
group (SD) 
Mean Result 
Control 
group 
(SD) 
Statistical 
Test and 
significance 
Effect 
Size 
Variables 
Matched 
Across Groups 
Quality 
Rating  
 
Ozyurt et 
al. (2014) 
VMLT  
Full  
 
 
Verbal 
Learning 
Delayed Recall 
Loss after delay 
LT Recognition 
T Scores 
 
 Median (IQR) 
46 (14) 
44 (15) 
55 (16) 
53 (6) 
Median (IQR) 
60 (9) 
58 (4.5) 
63 (7)  
54 (1) 
MWU 
(p=0.02) 
(p=0.001) 
(p=0.001) 
Not sig 
IDC Age, IQ, 
anxiety, 
depression 
High quality 
Shortman 
et al. 
(2014) 
CMS  
(5-16) 
All 
Subtests 
 
WMS 
(over 16) 
All 
Subtests 
 
Immediate 
Verbal LTM 
 
Composite 
scores 
  
98.8 (20.8)  
 
116.2 (16.7) 
ANOVA 
(p=0.018) 
 
d= -0.92 
SES, age, 
gender, 
educational 
attainment. 
 
Some survivors 
still being 
treated 
High quality 
 
Immediate 
Visual LTM 
 
Composite 
scores 
  
102.6 (24.5)  
 
120.3 (12.9) 
ANOVA 
(p=0.003)  
 
d= -0.90 
Delayed 
Visual LTM 
 
Composite 
scores 
  
109.2 (22)  
 
118.4 (13.9) 
ANOVA 
Not sig 
 
d= -0.5 
Delayed Verbal 
LTM  
Composite 
scores 
  
100.4 (19.7) 
 
113.8 (15) 
ANOVA 
Not sig 
 
d= -0.77 
General LTM Composite 
scores 
 104.3 (25.2) 124.1 (15.2) (p=0.021) d= -0.95 
Redmond 
et al. 
(2013)  
WJ 
Memory 
for Words 
Test  
Immediate 
Verbal LTM 
 
Raw score  
15month FU 
27month FU 
 
16.29 (2.95) 
16.6 (3.03) 
 
17.55 (1.7)  
18.3 (1.93) 
LME 
Not sig 
Not sig 
 
d= -0.50 
d= -0.67 
Matching of 
controls not 
discussed 
Acceptable 
quality 
Quintero -
Gallego et 
al. (2006) 
CVLT-C 
Learning 
trial 5 
Immediate 
Verbal LTM 
 
Raw Score 
 
Clinical 
subgroups 
Medullo-
blastoma 
 
11.28 (3.72)  
 
13.58 (1.37) 
MANOVA 
Not sig 
 
d= -0.82 
IQ not matched Acceptable 
quality 
Astrocytoma 12.36 (2.06) 13.58 (1.37) Not sig d= -0.70 
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Study Outcome 
Measure 
and 
Subtest 
Memory 
Function 
 
Outcome 
Score 
Group 
Analysis 
Mean Result 
Clinical 
group (SD) 
Mean Result 
Control 
group 
(SD) 
Statistical 
Test and 
significance 
Effect 
Size 
Variables 
Matched 
Across Groups 
Quality 
Rating  
 
Garcia-
Perez et al. 
(1994)  
 
 
 
Spreen 
Benton 
Sentence 
Repetition 
Immediate 
Verbal LTM 
 
Raw (out of 
26) 
Clinical vs 
Chronic 
disease 
 
22.17 (3.46) 
 
 
23.92 (2.91) 
ANOVA 
(Not sig) 
 
 
d= -0.56 
 
 
Age, parental 
SES, 
psychological 
impact of 
illness, 
cognitive ability 
High quality 
RCFT Immediate 
Visual LTM 
Standard score 
(M=50, 
SD=10) 
Clinical vs 
Chronic 
Disease  
 
45.80 (14.46) 
 
54.66 (10.08) 
MWU 
(p=0.022) 
 
IDC 
Yuste 
Memory 
Test 
General Long-
term memory 
Standard score 
(M=50, 
SD=10) 
Clinical vs 
Chronic 
Disease  
 
37.29 (9.85) 
 
51.92 (10.46) 
ANOVA 
(p=0.05) 
 
d= -1.44 
Spreen 
Benton 
Sentence 
Repetition 
Immediate 
Verbal LTM 
 
Raw (out of 
26) 
Clinical vs 
Non-CNS 
Cancer 
 
22.17 (3.46) 
 
23. 62 (2.65) 
 
ANOVA 
Not sig 
 
 
 
d= -0.47 
 
RCFT Immediate 
Visual LTM 
Standard score 
(M=50, 
SD=10) 
Clinical vs 
Non-CNS 
Cancer 
 
45.80 (14.46) 
 
55.66 (8.50) 
MWU  
(p=0.008) 
 
IDC 
Yuste 
Memory 
Test 
General Long-
term memory 
Standard score 
(M=50, 
SD=10) 
Clinical vs 
Non-CNS 
Cancer 
 
37.29 (9.85) 
 
49.01 (8.06) 
ANOVA 
(p= 0.05) 
 
d= -1.30 
 
Key 
ANOVA= Analysis of Variance 
CMS= Children’s Memory Scale 
CNS= Central Nervous System 
CVLT-C= California Verbal Learning Test- Child 
FU= Follow-up 
IQR= Inter Quartile Range  
IDC= Insufficient Data to Calculate effect size 
 
LME= Linear Mixed Effect Regression 
LT= Long Term 
LTM= Long-term memory  
MANOVA= Multivariate Analysis of Variance 
MWU= Mann-Whitney U 
RCFT= Rey Complex Figure Test 
SD= Standard Deviation 
SES= Socio-Economic Status  
 
VLMT= Verbaler Lern und Merkfahigkeitstest  
WMS= Wechsler Memory Scale 
WJ= Woodcock Johnson Test of Achievement
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Working Memory 
Verbal Working Memory in Paediatric Brain Tumour Survivors in Comparison to 
Healthy Controls 
High quality studies (Robinson et al., 2014; Riva et al., 2002) found evidence of significant 
differences in verbal WM between PBT survivors and healthy controls. Both studies had 
moderate small sample sizes, which may not have been representative of the PBT survivor 
population, however. IQ was not matched the study by Robinson et al (2014) or in all 
group comparisons within the Riva et al. (2002) study. As IQ is known to significantly 
correlate with working memory (Cowan, 2008), results may be due to underlying cognitive 
differences between groups. Psychological factors, which may affect performance on 
memory assessments, were matched within the Robinson et al., (2014) study, and Riva et 
al. (2002) used sibling controls, matching for social and family factors, strengthening the 
evidence for WM impairment in PBT survivors. Studies of acceptable quality reported 
varied results. Studies finding evidence of significant verbal WM impairments in PBT 
survivors compared to healthy controls (Law et al., 2011; Conklin et al., 2012) did not 
match for IQ, depression or anxiety, hence group differences may be a result of underlying 
cognitive and psychological variables. Redmond et al. (2013) found no group differences, 
but did not minimise the risk of bias through group matching or controlling for treatment 
and tumour effects. Collectively, these studies suggest verbal WM is impaired in PBT 
survivors compared to healthy controls but this may reflect underlying cognitive and 
psychological differences between groups.  
 
Certain treatments were associated with poorer WM in studies; PBT survivors treated with 
radiotherapy had poorer WM outcomes than those treated with surgery alone (Law et al., 
2011), as did those treated with Intrathecal Methotrexate (ITM) compared to those treated 
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without (Riva et al., 2002). No strong conclusions can be made regarding treatment effects 
on PBT survivors’ WM, however. There was also some evidence that working memory 
assessments that required both the temporary storage and manipulation of information 
were more impaired in PBT survivors relative to controls (Conklin et al., 2012; Quintero-
Gallego et al., 2006), suggesting that PBT survivors may be able to temporarily store, but 
not manipulate, information as well as healthy controls. Definitive conclusions cannot be 
drawn from the results as studies failed to minimise selection and detection biases.  
 
Verbal Working Memory in Paediatric Brain Tumour Survivors in Comparison to Non-
CNS Cancer Controls 
A high quality study comparing verbal WM in PBT and non-CNS cancer survivors found 
no differences between groups (Garcia-Perez, Sierra-Sesumaga, Narbona-Garcia, 
Calvomanuel and Aguirre-Ventallo, 1994). Although there was variability in ‘time since 
treatment’ (six months to ten years) and the level of radiation received within the brain 
tumour group, which may have influenced outcomes, cognitive ability was matched 
between groups, strengthening the conclusion. They also compared PBT survivors to 
young people who have a chronic disease and found no group differences in WM scores. 
Of the two studies of acceptable quality (Conklin et al., 2012; Mabbott et al., 2008), only 
one found differences in verbal WM between PBT and non-CNS cancer survivors, and 
only for a task involving both storage and manipulation of information. Collectively, these 
studies suggest that there may be generic illness and treatment factors that may affect 
verbal working memory in young people, however small sample sizes and heterogeneous 
PBT samples in the studies make generalising results to the PBT survivor population 
difficult.  
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Visual Working Memory in Paediatric Brain Tumour Survivors in Comparison to 
Healthy Controls 
Two studies, one of high quality (Riva et al., 2002) and one of acceptable quality 
(Redmond et al., 2013), found significantly poorer visual WM performance in PBT 
survivors than healthy controls, suggesting an impairment in visual in PBT survivors. Riva 
et al. (2002) only found differences in PBT survivors treated with ITM under the age of 
eleven, and healthy controls of the same age, which is not representative of the PBT 
survivor population. Furthermore, neither study matched groups for IQ in all groups, 
therefore differences may reflect cognitive ability rather than visual WM, reducing the 
strength of the conclusions. The multiple-choice version of the Benton Visual Retention 
Test (BVRT; Benton, 1950) utilised by Riva et al. (2002) had poor internal consistency in 
children (Wagner, 1992, cited in Strauss, Sherman & Spreen, 2006), further reducing the 
strength of conclusions that can be made regarding the data.  
 
Visual Working Memory in Paediatric Brain Tumour Survivors in Comparison to Non-
CNS Cancer Controls  
A single study of acceptable quality found no significant differences in spatial WM on in 
PBT and non-CNS cancer survivors (Mabbott et al., 2008). The brain tumour group only 
included survivors of posterior fossa tumours and results cannot be generalised to survivors 
of tumours in other locations, however this provides tentative evidence that spatial WM is 
not impaired in PBT compared to non-CNS cancer survivors.  
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Long Term Memory 
Verbal and Visual Long-Term Memory in Paediatric Brain Tumour Survivors in 
Comparison to Healthy Controls 
Two high quality studies comparing LTM in PBT survivors and healthy controls using 
sensitive and reliable assessments found PBT survivors were significantly impaired in 
verbal LTM relative to controls (Shortman et al., 2014; Ozyurt et al., 2014). Shortman et 
al. (2014) found evidence of impairment in immediate LTM recall following learning, but 
not after a 30-minute delay. Ozyurt et al. (2014) found evidence of delayed verbal LTM 
impairment after 30 minutes, however. Shortman et al. (2014) report that their study was 
underpowered due to the small sample size (although 25 in each group is moderate), which 
could have contributed to the null result after a delay. This is corroborated by the large 
effect size for group differences in verbal recall after a delay (-0.75).  
 
Shortman et al. (2014) also found evidence of visual LTM impairment in PBT survivors 
compared to healthy controls; again, group differences were significant for immediate and 
not delayed recall, however this may also be the result of the study being underpowered. 
As some PBT survivors had not yet or had only recently completed treatment in the 
Shortman et al. (2014) study, the sample may not be representative of the PBT survivor 
population, making results less generalizable and difficult to compare with the Ozyurt et al. 
(2014) study, which included survivors that had completed treatment years previously.  
 
The two studies of acceptable quality failed to find differences in immediate verbal recall 
in PBT survivors and healthy controls (Redmond et al., 2013; Quintero-Gallego et al., 
2006). Both studies failed to minimise the risk of bias by matching groups and included 
small sample sizes, which, they acknowledge, may mean the studies lacked the power to 
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detect group differences. Therefore strong conclusions cannot be drawn from them. 
Collectively, the studies suggest verbal and visual LTM are impaired in PBTS, 
corroborated by significantly lower global LTM scores in PBT survivors compared to 
controls (Shortman et al., 2014). Ozyurt et al. (2014) also found evidence that PBT 
survivors learned significantly fewer words during learning trials than the control group, 
and showed no impairment in recognition, suggesting words were stored but not retrieved.  
 
 
Verbal and Visual Long-Term Memory in Paediatric Brain Tumour Survivors 
Compared to Non-CNS Cancer Controls 
A high quality study comparing PBT and non-CNS cancer survivors found significant 
group differences in immediate visual LTM, but not immediate verbal LTM, although the 
effect size was medium (0.47) suggesting the study may not have had the power to detect 
group differences (Garcia-Perez et al., 1994). They found similar results when comparing 
PBT survivors with chronic disease controls, suggesting general illness or treatment factors 
(such as the psychological impact of illness and time away from school) may affect verbal 
LTM, and brain tumour and treatment factors may affect visual LTM. General LTM was 
also impaired in PBT survivors relative to non-CNS and chronic disease controls.  
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Discussion 
Main Findings 
Is there a significant working memory impairment in paediatric brain tumour survivors 
compared to controls? 
There was some robust evidence for verbal WM impairment in PBT survivors compared to 
healthy controls, but insufficient robust evidence of visual WM impairments. The lack of 
matching for IQ in all studies means group differences may be due to underlying cognitive 
ability, reducing the strength of conclusions made about WM in PBT survivors. It was 
unclear whether specific treatment modalities, age at treatment or time since treatment 
were associated with WM impairment. There was some evidence to suggest that tasks 
involving both the short-term storage and manipulation of information were more 
adversely affected in PBT survivors than tasks requiring simple serial recall, however 
further research is necessary to confirm this hypothesis. There was robust evidence that 
WM is not impaired in PBT compared to non-CNS cancer survivors, suggesting cancer 
treatment (chemotherapy or radiotherapy) may affect WM in young people, however this 
may be due to more general illness and treatment factors (fatigue, time off school, the 
psychological impact of illness) given the similarity in verbal WM scores between PBT 
survivors and young people with a chronic disease.  
 
Is there a significant impairment in long-term memory in paediatric brain tumour 
survivors compared to controls? 
Although there was variation across studies, high quality studies found significant 
impairments in immediate visual, and immediate and delayed verbal LTM in PBT 
survivors compared to healthy controls. Two studies of acceptable quality found no group 
differences in LTM, but they failed to control for confounders, reducing confidence in their 
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overall negative findings. There was robust evidence of immediate visual but not verbal 
LTM impairment in PBS survivors relative to non-CNS cancer and chronic disease 
controls. Collectively, the results suggest specific brain tumour and treatment factors may 
impact visual LTM in survivors of PBT.  
 
Other findings 
Radiotherapy in combination with surgery or chemotherapy may result in greater memory 
impairment in PBT survivors (Riva et al., 2002; Law et al., 2011). Mabbott et al. (2008) 
did not find any differences in WM outcomes in those treated with standard compared to 
reduced-dose radiation, although they included a non-CNS cancer control group rather than 
a healthy one, who also received cancer treatments. Overall, definite conclusions cannot be 
made regarding which variables have an impact on memory in this population.  
 
Methodological Quality and Risk of Bias 
The SIGN Checklist for Cohort studies identified that methodological quality varied across 
studies in the review. Five studies matched tumour and control groups for IQ or 
psychological factors, reducing selection bias and ensuring effects on memory are due to 
the brain tumour rather than other confounders. All the longitudinal studies reported 
participant drop-out between assessments, but none compared them with completers. If 
these groups differ significantly in confounding factors, it causes attrition bias and 
decreases the generalisability of study results. No studies reported whether assessors were 
blinded to group status of participants, which could have led to bias when delivering and 
marking assessments (detection bias). All outcomes were clearly defined, reliable and 
valid, and all studies reported using similar procedures for collecting data in both groups, 
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minimising further detection bias. Overall, articles controlled for age, gender and treatment 
factors well, but not intelligence and psychosocial factors.  
 
Context of Main Findings 
The results of the review correspond to the literature, which suggests impaired memory 
outcomes in brain tumour survivors when compared to normative data (Benesch et al., 
2009). Robinson et al. (2010) found larger mean effect sizes for verbal than visual memory 
outcomes, in line with working memory outcomes in the current review. Fewer studies in 
the current review assessed visual memory, however, which may be due to certain 
assessments being more popular, such as digit spans. The current review highlighted the 
lack of research assessing visual memory; future research should explore this in order to 
better understand which aspects of memory are most affected and how to best support 
survivors.  
 
The reviewed studies mainly included survivors who had completed treatment some years 
previously (Ozyurt et al., 2014), although one included survivors who had recently 
completed, or were still completing, treatment (Shortman et al., 2014). Previous 
longitudinal studies suggest that cognitive outcomes worsen in PBT survivors over time 
(Mulhern et al., 2004), and this may explain differences in findings between studies. The 
longitudinal articles in the current review did not all report deterioration in memory 
outcomes across time points, specifically between 15 and 27 months post-treatment. This 
does not contradict the literature as these time points are shorter than those normally 
reported in studies assessing long-term neurocognitive outcomes in PBT survivors.  
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Relevant Implications 
These results suggest memory should be clinically monitored in young people who have 
survived a brain tumour, as they may have significant impairments. The results would also 
be relevant to educational settings; educators should be aware that survivors may have 
difficulties retaining information and provide appropriate support to those that require it. 
There is currently more evidence to suggest verbal working and long-term memory are 
impaired in survivors relative to peers, therefore visual memory aids may be beneficial. 
The lack of articles comparing memory in PBT survivors and controls suggests the need 
for further research in this area. The evidence base would benefit from better designed 
studies that controlled for potential confounders such as IQ, treatment, tumour and 
psychosocial factors, and included larger sample sizes to improve the validity of results. 
Establishing a consensus in memory terminology and the functions assessed in different 
assessments would also increase the validity of conclusions drawn from the literature and 
allow comparisons between studies to be more easily made. For example, the use of the 
term ‘short-term memory’ in relation to immediate recall following learning trials is 
disputed and this could be addressed in future. 
 
Strengths and Limitations of the Review 
The methodological quality tool developed by SIGN is standardised and validated and was 
a good assessment of methodological quality in the reviewed studies. It did not 
differentiate between studies very well, therefore specific confounders deemed to be 
significant were used to identify high and acceptable quality studies. As this was somewhat 
subjective, the quality ratings may have negatively affected the reliability, although this 
was minimised by the use of a second rater.  
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There are general challenges in reviewing literature from this population. Samples are 
often small and heterogeneous due to the small population. Data are often collected as part 
of treatment protocol studies, thus battery of assessments could be included in the 
protocols to collect more extensive data on cognitive outcomes in survivors. The current 
review included studies between 1994 and 2014, during which time treatments for cancer 
have developed and become less damaging to the brain. The reviewed articles also varied 
in tumour diagnoses and locations. The synthesis of the findings would have been more 
valid if these factors had been reviewed separately. This could not be accomplished due to 
the small sample sizes within articles. The review included only articles with paediatric 
populations. Research into cognitive late-effects suggests some functions deteriorate with 
time following treatment, so including studies with adults who had survived a paediatric 
brain tumour may have delivered more robust results. The review focused on memory only 
and executive functions may affect memory performance. Including executive functions in 
the review may have improved the strength of conclusions. A publication bias towards the 
publication of significant findings only may also account for some of the results, 
influencing how meaningful they are.  
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Conclusions 
There is robust evidence of verbal working memory and verbal and visual long term 
memory impairments in paediatric brain tumour survivors compared to healthy controls. 
There was insufficient robust evidence to make conclusions regarding visual working 
memory. Memory can affect both educational and everyday functioning in PBT survivors. 
The results of the current review could therefore be used to better support this group of 
young people, both in educational and home settings. Systematic assessment on return to 
school and subsequent follow-up assessments every six months could be included in 
routine follow-up. Results are also applicable clinically, confirming the importance of 
memory assessments in PBT survivors in order to recognise impairments early and provide 
support as quickly as possible. 
 
The lack of high-quality articles comparing tumour and control groups means further 
research is required to understand the long-term effects of brain tumours and their 
treatment on memory in young people, in order to improve understanding of which 
memory functions are most impaired in survivors.  
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Plain English Summary 
Background Some children and young people who have survived a brain tumour have 
poor memory. They report finding it difficult to remember information they learned at 
school for exams, which may be because they forget more information than other people of 
their age. Poor sleep, depression and anxiety can affect how well you remember things and 
can be common in young people who have had a brain tumour.  
Aims To explore whether young people who have survived a brain tumour can learn and 
remember information as well as their siblings, cousins or best friends. A second aim is to 
explore whether memory is related to sleep quality, depression and anxiety in young 
people who have survived a brain tumour.   
Method Young people between the ages of 11 and 24 who had survived a brain tumour 
were taught a list of words and a shape. They were asked to remember as much as they 
could 30 minutes later and again after a week. They also filled in questionnaires about their 
mood and wore an Actiwatch for one week, which measured how well they slept.  
Results Young people who survived a brain tumour found it more difficult to learn the 
word list than their siblings/cousins/best friends. Some of the brain tumour survivors found 
it very difficult to remember the words and shape, especially after a week, but others 
remembered them as well as their friends or family. Brain tumour survivors may have 
different memory abilities because there was a range of different brain tumour diagnoses 
and treatments in the group. The results suggest that schools and hospitals should monitor 
survivors to make sure they get support if they do have these difficulties. Memory was not 
associated with sleep, depression or anxiety in the survivors, but the study was small so 
more studies are needed to look at which groups of brain tumour survivors have poor 
memory and how their sleep and mood affects this.  
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Abstract 
Background The literature suggests that working and long-term memory are impaired in 
paediatric brain tumour survivors (Robinson Fraley, Pearson, Kuttesch & Compas, 2013; 
Robinson et al., 2014). Survivors report difficulties remembering information they learned 
days before, including for school exams. Sleep and psychological problems can affect 
memory performance and may exacerbate memory difficulties in this population.  
Aims Assess learning and long-term memory in paediatric brain tumour survivors relative 
to healthy controls, and explore associations between memory, sleep and mood.  
Method A learning paradigm was used to teach verbal and visual material to an 80 percent 
criterion in ten young brain tumour survivors and ten matched healthy controls (sibling, 
cousin or best friend) aged between 11 and 24. A between-subjects design compared recall 
between groups at delays of 30 minutes and one week. Sleep quality (measured by 
Actigraphy), anxiety and depression were also assessed.  
Results Verbal learning was significantly impaired in brain tumour survivors relative to 
controls. There was very tentative evidence of increased visual forgetting in the tumour 
group, however definitive conclusions could not be drawn from results due to the study 
lacking power. Some participants had significant impairments in verbal learning or verbal 
and visual long-term memory, and others did not. Memory was not associated with sleep or 
psychological variables in the tumour group, although this may be due to the study lacking 
power.  
Discussion The variability in memory within the tumour sample emphasises the 
heterogeneity in the brain tumour population and the need for memory to be monitored in 
individuals. Education and occupational settings could offer further support to those that 
require it. Future research should assess memory after delays longer than 30 minutes and 
further explore how tumour, treatment, sleep and mood variables affect memory.  
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Introduction 
In the United Kingdom, 24.5 percent of all new cancer diagnoses in children below the age 
of 14 are due to central nervous system tumours (Stiller, 2007). The most common 
diagnoses of paediatric brain tumour (PBT) are medulloblastoma (a high grade, fast 
growing tumour), pilocytic astrocytoma and craniopharyngioma (low grade tumours). 
Survival rates in young people with brain tumours have improved drastically over the past 
twenty years as a result of treatment advances, however the treatments can be damaging to 
healthy tissue, such as through neurosurgical resection, and chemotherapy and/or 
radiotherapy, which can be neurotoxic (Turner, Rey-Casserly, Liptak, & Chordas, 2009).  
 
Children and young people who have been treated for a brain tumour can experience 
cognitive deficits including memory and language (Robinson et al., 2010). In addition, 
children may miss months or even years of school and have ongoing educational 
interruptions during treatment, which could have a further negative effect on learning.  
 
 
Memory  
Baddeley and Hitch (1974) suggest memory is made up of two systems that interact: 
working memory and long-term memory (LTM). Working memory is a multi-component 
system that includes the temporary storage and manipulation of information and LTM 
includes the long-term storage of information. The Standard Consolidation Model 
(Hasselmo and McClelland, 1999) suggests that information from working memory is 
encoded in the hippocampus then consolidated to the long-term store within the neocortex, 
creating new neural pathways between the hippocampus and neocortex. Standard memory 
assessments measure LTM immediately following learning trials for a stimulus, and after a 
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thirty minute delay. PBT survivors were found to have poorer delayed than immediate 
recall of verbal and visual information, suggestive of impaired consolidation (Carpentieri 
et al., 2001). 
 
There is evidence that the process of consolidation can take several days, and is vulnerable 
to disruption. Children with epilepsy forget a higher proportion of information than healthy 
controls after a week, a phenomenon called ‘accelerated forgetting’, suggesting seizures 
may be affecting consolidation (Davidson, Dorris, O’Regan and Zuberi (2007). 
Chemotherapy and radiotherapy can damage the development of white matter in the brain 
(Reddick et al., 2003), which may affect the integrity of the neural pathways between the 
hippocampus and neocortex. This may affect consolidation in PBT survivors, therefore 
standard measures may not be appropriate to assess consolidation in this population.  
 
Anecdotal evidence from studies suggests that PBT survivors have difficulty remembering 
information over longer time periods, including for school exams (Waber et al., 2006). 
Parents have also reported their children having difficulty applying information they had 
previously learned (Ondrucht, Maryniak, Kropiwnicki, Roszkowski, & Daszkiewicz, 
2011). Collectively, this suggests brain tumour survivors may have difficulty retrieving 
material previously encoded into LTM, or may forget more rapidly than peers. As this 
would significantly affect learning, longer term memory retention should be explored in 
this population.  
 
Memory, Sleep and Psychological Factors 
Good sleep is important for memory consolidation (Maquet, 2001) and PBT survivors 
experience sleep problems in initiating and maintaining sleep, hypersomnia and fatigue 
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(Verberne, Maurice-Stan, Grootenhuis, Van Santen, & Schouten-Van Meeteren, 2012). 
Impaired working memory was associated with poorer sleep quality and increased 
sleepiness in adult survivors of childhood cancer, after controlling for age, gender and 
treatment (Clanton et al., 2011). Depression and anxiety have been associated with poor 
academic performance in healthy children (Owens, Stevenson, Hadwin, & Norgate, 2012) 
and brain tumour survivors can have significantly higher levels of distress and depression 
than sibling controls (Zebrack et al., 2004), which may exacerbate memory difficulties. 
Should these factors be associated with memory, evidence-based interventions for children 
to ameliorate low mood, anxiety and sleep quality, and cognitive rehabilitation techniques, 
may enhance memory (Compton et al., 2004; Kesler, Lacayo and Jo, 2011).  
 
The Current Study 
This study explored memory and its relationship to sleep, anxiety, and depression on in 
PBT survivors. It was hypothesised that PBT survivors have impaired retention of learned 
information after a delay of days or weeks that may not be evident in a delay of half an 
hour, therefore memory was assessed at a 30 minute and one week delays in PBT survivors 
and healthy controls. There is evidence to suggest several factors affect cognitive 
functioning in brain tumour survivors, such as age at diagnosis, severity of tumour, 
treatment received and location of tumour. Due to the time and recruitment limitations in 
the scope of the study, these factors were not controlled for, but tumour and treatment 
factors are described (Table 1).  
 
Hypotheses  
1. PBT survivors have significantly lower scores on working memory tests than 
healthy controls 
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2. PBT survivors require significantly more trials to learn verbal and non-verbal 
information than healthy controls.  
3. PBT survivors have lower recall and recognition scores after a 30 minute delay and 
significantly lower recall and recognition scores after a one week delay than healthy 
controls. 
4. PBT survivors forget a significantly greater proportion of learned verbal and visual 
information between 30 minute and one week delays than healthy controls. 
5. Better memory performance is associated with better sleep quality and lower self-
reported anxiety and depression in PBT survivors. 
 
 
Method 
Design  
A prospective, within and between-subjects design compared LTM in PBT survivors and 
healthy age-matched sibling, cousin or best friend controls.  
 
Participants  
Inclusion Criteria 
Young people who had received treatment for a brain tumour at the Royal Hospital for 
Sick Children (RHSC) in Edinburgh between the ages of 11 (the age secondary education 
commences) and 24 years (the age to which paediatric oncology reviews continue) at time 
of recruitment were eligible. Exclusions were not made on the basis of tumour type or 
location, or treatment type. Treatment had to have been completed at least six months prior 
to recruitment. Healthy siblings, cousins or best friends of tumour participants aged 
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between 11 and 24 were recruited as controls for psychosocial, family and environmental 
factors. All participants had to be fluent in English.  
 
Exclusion criteria 
PBT survivors were excluded if they had a secondary cancer for which they were receiving 
chemotherapy or radiotherapy. Controls were excluded if they had a history of cancer or 
other neurological diagnoses (including head injury and neurological infection) or had 
been admitted to hospital in the 6 months previous. Young people were excluded if they 
had a diagnosis of a developmental disorder, such as Autistic Spectrum Disorder or 
Learning Disability, were being treated for a mental health disorder, or had received a 
recent cognitive assessment.   
 
Sample size  
No studies assessing longer-term memory have been conducted in PBT survivors, so an a 
priori sample size calculation was based on Davidson et al. (2007) as it most closely 
resembled the current design. They found significant differences in recall on the Stories 
Subtest of the Children’s Memory Scale in 21, 6-16 year olds with epilepsy and 21 healthy 
controls matched for age and IQ, after a one week delay. G-power was used to calculate 
the sample size required for an independent t-test (epilepsy group: M= 75.8 (SD=13.8); 
control group: M= 84.4 (SD= 6.8)). Assuming a normal distribution, two-tailed analyses, a 
significance level of 0.05 and power at 0.80, a sample size of 27 in each group was 
estimated to find a large effect size1. As the current study used sibling controls, paired t-
                                                          
1 The sample size calculation differed from that in the proposal following consultation with 
a statistician. 
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tests would be used, which have higher power to detect any effects, therefore a smaller 
sample would be required. A sample of 20 in each group was the target for recruitment.   
 
Recruitment Procedure 
Approval was obtained from West of Scotland NHS Research Ethics Service and NHS 
Lanarkshire and NHS Lothian Research and Development (Appendices 2.2, 2.3, 2.4). The 
Research Oncology Nurse identified and contacted 53 brain tumour survivors eligible for 
recruitment. Young people who had survived a Medulloblastoma were recruited first, but 
as the response rate was low, Pilocytic Astrocytoma and Craniopharyngioma survivors 
were also recruited.  
 
Potential participants (or parents of those under 16) were sent information regarding the 
study by post. Those that were interested were asked to contact the Research Oncology 
Nurse, or to return the consent form. Consultant Oncologists were available to answer 
questions within clinical review appointments. Posters were displayed in hospital waiting 
areas to aid recruitment. Control subjects were recruited through PBT survivors or their 
parents. Twelve PBT survivors consented to be contacted, a response rate of 23 percent. 
They were contacted by the researcher for initial screening and to organise assessment 
sessions. Two PBT survivors and their controls failed to attend. Of the remaining ten, two 
participants in the tumour group did not have an appropriate control; for these participants, 
unrelated healthy controls were recruited through the researcher’s work colleagues and 
were matched to PBT survivors based on their age only. In total, ten PBT survivors and ten 
controls participated.  
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Research Procedure 
Each participant attended two sessions, one week apart. In the first session, cognitive and 
memory assessments were completed, in the second, memory assessments were re-
administered and mood and sleep questionnaires completed. All sessions were conducted 
in an outpatient hospital setting or a local health centre if more convenient for families. 
Written assent was obtained for 11 year olds, and consent for those 12 years and above. 
Further consent was obtained from parents of participants under sixteen. Participants were 
given an Actiwatch to wear over the week. Participants were asked not to discuss the 
assessments with their control during the week between assessments and were not aware 
they would be asked to recall information after one week. Data collection occurred 
between February and June 2015. 
 
Measures and Equipment 
Intellectual Functioning  
The two-subtest version of the Wechsler Abbreviated Scale of Intelligence- Second Edition 
(WASI-II; Wechsler, 2011) was used to estimate full-scale IQ. It comprises Matrix 
Reasoning (a measure of visual abstract reasoning) and Vocabulary (a measure of verbal 
comprehension) subtests. It is standardised for ages 6-90 years. An IQ score was calculated 
for each participant (WASI IQ scores have a mean of 100 and standard deviation of 15).  
 
Working Memory 
Working memory was estimated using the Digit Span subtest of either the Wechsler 
Intelligence Scale for Children-Fourth Edition (WISC-IV; Wechsler, 2003) for those aged 
11-15 years, or the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; 
 
 
50 
 
Wechsler, 2008) for those aged 16 to 24 years. The totals of raw scores for backward and 
forward digit span were calculated for each participant. 
 
Long-Term Memory 
The Rey Auditory Verbal Learning Test (RAVLT; see Lezak, Howieson, & Loring, 2004) 
was used to assess auditory verbal memory. The 15 word list was read aloud by the 
researcher and participants were asked to recall the words. The normal testing procedure 
includes five learning trials. This was changed for the purpose of this research and a 
learning paradigm was employed. Participants received learning trials repeatedly until they 
achieved a learning criterion of 80 percent accuracy (12/15 words). If participants did not 
achieve this criterion, the number of trials they were given before they asked to stop was 
recorded. This replicates the learning procedure used by Davidson et al. (2007). 
Participants were then assessed on free recall at 30 minute and one week delays, and 
recognition from a list of 50 words.  
 
The Rey Complex Figure Test (RCFT; Meyers & Meyers, 1996) was given to assess 
visuo-spatial memory. Participants were shown the design and asked to copy it, the design 
was then obscured and participants were asked to recall it from memory. The normal 
procedure was altered and a learning paradigm was employed (as above). Recall was 
assessed after 30 minute and one week delays, followed by recognition of 12 elements 
within the Rey Complex Figure from 24 items (converted into a percentage). 
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Anxiety and Depression  
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) was used to 
measure anxiety and depression symptoms. Although originally normed against an adult 
population, it has been validated in a sample of children aged between 12 and 17 (White, 
Leach, Sims, Atkinson, & Cottrell, 1999). They found the HADS to have reasonable test-
retest reliability (r=0.62 for depression subscale and 0.74 for anxiety) and to discriminate 
between adolescents with and without diagnoses of anxiety or depressive disorders.  
 
Sleep 
Actigraphy has been found to be an objective measure of sleep quality (Sadeh & Acebo, 
2002). Participants wore an ‘Actiwatch’ AW4 series (produced by CamNtech in 1996), 
which is a watch-like device that measures activity levels during sleep on their non-
dominant wrist. The Actiwatch was worn for one week, adhering to recommendations of 
five week nights for reliably calculating sleep efficiency in children (Acebo et al., 1999). 
Participants were asked to press the Actiwatch button when they turned off the lights at 
night, to record this time point for analysis. Actiwatch Sleep 7 software was used to 
calculate sleep efficiency (total time asleep divided by total time in bed multiplied by 100, 
indicative of the proportion of time you are asleep when trying to sleep), sleep latency 
(how many minutes it takes to fall asleep), percentage of time in ‘immobile sleep’ (number 
of immobile minutes divided by number of minutes of assumed sleep, which indicates the 
proportion of deep sleep), and the Fragmentation Index (the proportion of movement 
within sleep, which is an indication of increased restlessness in sleep; The Actiwatch User 
Manual V7.2; CamNtech, 2008). Participants also completed a sleep diary (see Appendix 
2.5 for details), to provide corroboration of Actiwatch data and allow the sleep factors to 
be calculated more accurately.  
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The Sleep Self-Report (SSR; Owens, Spirito, McGuinn, & Nobile, 2000), a retrospective, 
self-rated measure of sleep habits, problems falling asleep, sleep duration, night waking 
and daytime sleepiness was used to measure sleep subjectively. It comprises 18 questions 
and higher scores represent greater sleep disturbance (Owens, Spirito, McGuinn, & Nobile, 
2000). It shows good psychometric reliability (internal consistency estimated at 0.71; 
Lewandowski, Toliver-Sokol and Palermo, 2011) and although created for children 
between 7 and 12 years, it has been used with adolescents (Sumpter et al., 2013). 
Permission to use the tool was granted by the author (Appendix 2.6). The Fatigue Scale-
Adolescent (Hinds et al., 2007; Mandrell et al., 2011) is a 13 item self-report measure for 
fatigue for 13 to 18 year olds with cancer. It was found to have good reliability (internal 
consistency 0.87) and identify patients with high and low fatigue with adequate sensitivity 
(Mandrell et al., 2011). The first part of the scale was used, as the second relates 
specifically to current cancer and treatment factors. Permission to use the tool was given 
by the author (Appendix 2.6).  
 
Data Analysis  
The distributions of the data were analysed for normality based on histograms, Q-Q Plots 
and the Shapiro-Wilk test for normality. Only the data in two variables were normally 
distributed, and paired samples t-tests were used to compare groups. Paired-samples 
Wilcoxon signed rank tests (WSRT) were used to compare groups where distributions 
were not normally distributed and not appropriate for transformation, as most controls 
were related in some way to the tumour group. Effect sizes for non-parametric data were 
calculated as follows (Rosenthal, 1994): 
r= Z/√n.  
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Rosenthal (1994) suggests an effect size for r of 0.1 is small, 0.3 medium and 0.5 large.  
Participants who did not reach learning criterion on memory assessments were assigned a 
valued based on the number of trials they completed before asking to stop the assessment, 
in order for them to be included in the analyses. It was not appropriate to apply regression 
models due to the data not meeting parametric assumptions, therefore relationships 
between memory, anxiety, depression and sleep quality were analysed using non-
parametric Spearman correlations. 
 
 
 
Results 
Participant Characteristics 
The clinical characteristics of the ten PBT survivors (five male, five female) are 
summarised in Table 1. The ten control participants (four male, six female) comprised five 
siblings, one cousin and two friends of the tumour group, and two unrelated healthy 
controls. The tumour group was aged between 13 years and one month and 25 years at 
time of assessment; median age was 17 years and 5 months (interquartile range (IQR) 5). 
Five were in full-time education (of these, two were on study leave), two were in full-time 
employment and three were unemployed. The control group were aged between 11 years 5 
months and 23 years 7 months. Median age was 17 years (IQR 8). The groups did not 
differ in age (WSRT; W=19, Z= -0.867, p=0.386, effect size -0.19). Six controls were in 
full-time education (of these, three were on study leave), two were in full-time 
employment and two were unemployed. Socio-economic status was estimated using the 
Scottish Index of Multiple Deprivation (SMID; Scottish Government, 2012), and was 
calculated for each participant using their home address, through the Scottish 
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Neighbourhood Statistics website. Eight PBT survivors and seven controls had SIMD 
scores indicating they are not in disadvantaged areas; one PBT survivor had an SIMD 
score indicating they were within the most deprived 20-25 percent in Scotland, and one 
PBT survivor and one control were in the most deprived five percent in Scotland. Home 
addresses were not available for two controls; although one had recently moved out of the 
family home. The tumour group had an estimated median IQ of 103.5 (IQR 15) and the 
control group of 108 (IQR 16). Groups did not differ in estimated IQ (WSRT; W=42.5, 
Z=1.53, p=0.126, effect size -0.34). 
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Table 1. Clinical Characteristics of the Tumour Group 
Participant Age at 
Diagnosis 
(years) 
Age at 
Treatment 
(years) 
Time Since 
Treatment 
(years) 
Age at 
Assessment 
(years) 
Tumour 
Diagnosis 
WHO 
Tumour 
Grade 
Location of 
Tumour 
Extent of 
Surgical 
Resection 
Radiotherapy 
Treatment 
Chemotherapy 
Treatment 
1 11 11-12 5 17 Craniophary
ngioma 
1 Pituitary Fossa Tumour 
drainage and 
surgical 
debulking 
Focal Photon  
2 8 8 6 14 Pilocytic 
Astrocytoma 
1 Posterior 
Fossa and 
Fourth 
Ventricle 
Incomplete 
resection 
and surgical 
debulking 
  
3 2 Watch and 
wait for 10 
years 
12-16 
2 18 Pilocytic 
Astrocytoma 
1 Suprasellar Incomplete 
resection 
and surgical 
debulking 
Focal Photon Carboplatin and 
Vincristine 
4 5 5 8 13 Pilocytic 
Astrocytoma 
1 Posterior 
Fossa 
Complete 
resection 
  
5 4 4 13 17 Pilocytic 
Astrocytoma 
1 Posterior 
Fossa 
Complete 
resection 
  
6 14 15 3 18 Pilocytic 
Astrocytoma 
1 Suprasellar 
located in 
hypothalamus 
Surgical 
debulking 
Focal Photon Vinblastine 
7 11 11 12 23 Cranio-
pharyngioma 
 Pituitary Fossa Surgical 
debulking 
Focal Photon  
8 10 10 5 15 Medullo-
blastoma 
4 Right 
Cerebellum 
Incomplete 
resection 
Cranio-spinal Vincrtistine 
followed by 
Packer 
Chemotherapy 
9 14 14 4 18 Pilocytic 
Astrocytoma 
1 Left Occipital 
and Parietal 
Incomplete 
resection 
  
10 11 12 13 25 Pilocytic 
Astrocytoma 
1 Optic Chiasm, 
Suprasellar 
extension 
Not 
specified 
Focal Photon  
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Memory (see Table 2) 
Working Memory 
There were no significant differences in total raw scores on the forward and backward digit 
span tasks between groups; hypothesis 1 was not supported.  
 
Learning and Encoding 
Hypothesis 2 was supported for verbal but not visual material.  
Visual Memory 
The RCFT was not administered to one participant in the tumour group who was visually 
impaired. The number of trials required to learn the shape to the 80 percent criterion did 
not differ between groups.  
 
Verbal Memory 
Three participants in the tumour group did not reach the 80 percent learning criterion on 
the RAVLT; one asked to stop after seven and two after eleven trials (used as coding 
values for analyses). When included in analyses, the tumour group required significantly 
more learning trials to learn verbal material than the control group (significance remained 
after a Bonferroni Correction was applied). When those that did not reach criterion were 
excluded from analyses, the number of learning trials required to reach criterion did not 
differ significantly between groups. 
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Table 2. Summary of results and statistical analyses comparing tumour and control groups 
 
Measure  Tumour Group 
Mean (SD) 
Median (IQR) 
N Control Group 
Mean (SD) 
Median (IQR) 
N Statistical 
Analysis  
n in 
analysis 
Test 
statistics 
Significance Effect 
size 
WAIS/ 
WISC 
Digit Span Forward and Backward 
(Raw score) 
16 (4) 10 19 (7) 9 RSWSRT 18 W= 23 
Z= 1.521 
p= 0.128 r= -0.36 
RCFT Number of Learning Trials to 
Criterion 
 
3 (3) 9 2.5 (2) 10 RSWSRT 18 W= 16 
Z=-0.778 
p= 0.436 r= 0.18 
30 Minute Recall (Raw score) 
 
29.5 (2.5) 9 30.75 (5.1) 10 RSWSRT 18 W= 25.5 
Z= 0.356 
p=0.722 r= -0.08 
30 Minute Recognition (Percentage) 
 
91.67 (16.67) 7 91.67 (14.59) 8 RSWSRT 14 W= 6.5 
Z= -0.271 
p= 0.786 r= 0.07 
1 Week Recall (Raw score) 
 
24 (4.3) 9 27.5 (5.3) 10 RSWSRT 18 W= 38 
Z= 1.843 
p= 0.065 r= -0.43 
1 Week Recognition (Percentage) 
 
91.67 (8.34) 7 83.33 (20.84) 6 RSWSRT 10 W= 1 
Z= -0.447 
p= 0.655 r= 0.14 
Forgetting (Percentage) 
 
15.09 (13.03) 9 8.24 (5.65) 10 RSWSRT 18 W=7 
Z= -1.836 
p=0.066 r= 0.43 
RAVLT Number of Learning Trials to 
Criterion 
 
5 (5) 10 3 (0) 10 RSWSRT 20 W=2 
Z=-2.254 
p= 0.024 r= 0.50 
30 Minute Recall (Raw score) 
 
10 (6) 10 9.5 (4) 10 RSWSRT 20 W= 31.5 
Z= 0.409 
p=  0.683 r= 0.09 
30 Minute Recognition (Percentage) 
 
100 (13.33) 10 96.67 (8.34) 10 RSWSRT 20 W= 16.5 
Z=0.431 
p= 0.666 r= -0.10 
1 Week Recall (Raw score) 
 
7 (5) 10 7.5 (3) 10 RSWSRT 20 W= 33.5  
Z= 1.310 
p= 0.190 r= -0.29 
1 Week Recognition (Percentage) 
 
93.33 (13.33) 10 93.33 (11.66) 8 RSWSRT 16 W=13 
Z= 0.530 
p= 0.596 r= -0. 13 
Forgetting (Percentage) 
 
20 (26.52) 9 12.5 (25.82) 10 RSWSRT 18 W= 8 
Z= -1.40 
p=0.161 r= 0.33 
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Key 
RAVLT= Rey Auditory Verbal Test 
RCFT= Rey Complex Figure Test 
RSWSRT= Related Samples Wilcoxon Signed 
Rank Test 
SD= Standard Deviation 
WISC= Wechsler Intelligence Scale Children 
WAIS= Wechsler Adult Intelligence Scale 
 
Effect sizes: Positive if tumour group has higher 
value and negative if tumour group has lower value
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Recall and Recognition 
Hypothesis 3 was partly supported. 
Visual Memory  
Recall on the RCFT did not differ between groups at 30 minutes and there was a non-
significant trend towards lower recall scores in the tumour group after a one week delay, 
although this did not remain following Bonferroni correction. Recognition of the visual 
elements of the RCFT as a percentage of the maximum did not differ between groups at 
either delay. 
 
Verbal Memory  
Data were analysed with the inclusion of participants that did not reach the learning 
criterion because excluding them would not represent the range of learning difficulty in the 
sample. Recall and recognition did not differ significantly between groups at either delay. 
There was a large variation in recall within the tumour group, however. One PBT survivor 
was unable to recall any words at either delay, and a further PBT survivor recalled only 4 
words after 30 minutes, far below the median for the group.  
 
Forgetting 
The proportion of information forgotten between 30 minute and one week delays was 
calculated using the formula described by Narayanan et al. (2012):  
Percentage information forgotten= 100 x   30 minute recall – one week recall  
       30 minute recall 
 
 
Hypothesis 4 was partly supported. There was a trend towards greater forgetting of visual 
information in the tumour group than in the control group, although this did not remain 
following Bonferroni correction. The tumour group showed greater variability than the 
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control group, with three participants forgetting five to ten percent more visual information 
than the group median, suggesting poor visual retention. One participant was not included 
in the verbal forgetting data because their recall on the RAVLT was zero at both time 
points. Groups did not differ in the proportion of verbal material they forgot over the week 
and both groups showed high variability in forgetting.  
 
Relationship Between Memory, Sleep and Psychological Factors  
Actigraphy was analysed using Sleep 7 software and sleep diaries were used to infer times 
of lights out and lights on, between which time subjects were trying to sleep. As half of the 
participants were either on leave from school/college or were unemployed and had little 
routine during the week, it was felt that using only weekdays to calculate sleep variables 
would not be valid. Adherence to wearing the Actiwatches during the night was variable; 
four controls did not wear an Actiwatch for two or three nights, and three PBT survivors 
did not wear one for between two and five nights. Average sleep variables were therefore 
computed from all available nights for each participant, to increase reliability of the data. 
Further analyses on sleep and psychological variables are reported in Appendix 2.7. 
 
Correlations (Spearman’s Rho) were calculated between the memory, sleep and 
psychological variables in the tumour group. Correlations between memory and sleep or 
psychological variables were non-significant (p>0.05); hypothesis 5 was not supported.  
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Discussion 
Main Findings in Relation to the Literature 
Working Memory 
Working memory was not significantly impaired in PBT survivors relative to healthy 
controls in the current study, however this result should be interpreted with caution 
because the study lacked the power to detect any group differences. This may be the reason 
it differs from the literature, which suggests that verbal working memory is impaired in 
PBT survivors relative to healthy controls (Robinson et al., 2014; Riva et al., 2002; Law et 
al., 2011, Conklin et al, 2012). Unlike the current study, many studies failed to control for 
IQ, which correlates with working memory, and may also explain differences in results.  
 
Learning and Encoding 
PBT survivors required significantly more trials to learn verbal (but not visual) material 
than controls, however there was large variability in the number of learning trials required 
on the RAVLT. Some PBT survivors required only a few trials but three PBT survivors felt 
unable to learn the word list to the criterion level, suggestive of significant verbal learning 
deficits. Ozyurt et al. (2014) found that survivors of craniopharyngiomas learned 
significantly fewer words than healthy controls matched for age and intelligence, 
consistent with the current study. Di Pinto et al. (2012) found that craniopharyngioma and 
low grade glioma survivors treated with surgery and focal radiotherapy had normal verbal 
learning, however they reported that survivors treated with pre-irradiation chemotherapy 
were more impaired. The current sample included PBT survivors who received a variety of 
treatments, including chemotherapy, and used a control group rather than norms to infer 
impairment, which may account for the differences between results.  
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Recall and Forgetting 
As the study had a modest sample size and lacked the power to detect true effects, 
definitive conclusions cannot be drawn from the results regarding group differences in 
recall and forgetting. Although it is difficult to reliably answer whether LTM is impaired in 
PBT survivors, there was very tentative evidence of survivors forgetting more visual 
material after one week than controls (although the non-significant trend did not remain 
once multiple comparisons were controlled for) and of larger group differences in recall at 
one week than 30 minute delays. It was evident that verbal recall and visual retention 
abilities varied within the tumour group; some PBT survivors showed similar abilities as 
controls, others showed significant impairments suggestive of LTM deficits. This may be a 
reflection of the varied treatment and tumour factors in the sample and it emphasises the 
heterogeneous nature of the PBT survivor population.  
 
Collectively, these results tentatively suggest that the consolidation of verbal and visual 
information may take a few days and that this may be disrupted in some PBT survivors, 
causing difficulty in retaining information over longer time periods. This supports the use 
of longer delays when assessing memory in this population.  
 
Research comparing PBT survivors and healthy controls provides robust evidence for 
impairments in verbal LTM (Ozyurt et al., 2014) and visual LTM (Shortman et al., 2014). 
This was not found in the current study and may reflect differences in samples and 
measures, or the lack of power in the current study. Further research is required to explore 
memory retention in this population as definitive conclusions cannot be drawn from the 
current results.  
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Recognition 
Recognition memory for verbal and visual information did not differ between groups, 
suggesting brain tumour and treatment factors had little effect on the process of identifying 
whether a stimulus had been encountered previously. Intact recognition in the sample is in 
line with previous research (Ozyurt et al., 2014).   
 
Relationship Between Memory, Sleep and Psychological Factors  
There is evidence that impaired memory is associated with poor self-reported sleep quality 
in adult survivors of childhood cancer (Clanton et al., 2011), and that depression and 
anxiety are associated with poor academic performance in healthy children (Owens, 
Stevenson, Hadwin, & Norgate, 2012). Memory was not associated with any sleep or 
psychological factors in PBT survivors in the current study, which is likely due to the study 
lacking power to detect significant correlations. The Actigraphy data should be interpreted 
with caution, as it was often difficult to interpret and contained missing data, which may 
have reduced its validity. It is therefore difficult to reliably answer whether sleep, 
psychological factors and memory are associated in PBT survivors, therefore further 
research is required.  
 
 
Strengths and Limitations of the Research and Future Directions 
The main limitation was the modest sample size, which meant definitive conclusions 
regarding learning and LTM impairment in PBT survivors relative to controls could not be 
made. There were several limitations that influenced recruitment that contributed to this, 
primarily the small brain tumour survivor population in Scotland and recruiting from a 
single centre, where only 53 potential participants were identified. Time limitations and the 
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high demand from participants (meeting twice, a week apart) with no incentives also 
affected recruitment. The low opt-in rate resulted in a heterogeneous tumour sample which 
may not be representative of other young people who have survived a PBT, increasing the 
risk of selection bias.  Previous research has shown that tumour and treatment factors 
affect memory in survivors (Shortman et al., 2014; Robinson et al., 2013; Di Pinto et al., 
2012, Riva et al. 2002), but subgroup analyses were not appropriate due to the modest 
sample size.  
 
Another limitation was the validity of the Actigraphy data. Actigraphy has been found to 
be an objective measure of sleep (Sadeh & Acebo, 2002), but it has also been criticised for 
not reliably distinguishing still wakefulness and sleep (Sadeh and Acebo, 2002). Similar to 
the current study, previous research including adolescents reported low compliance in 
Actiwatch use (Acebo et al., 1999). Data from less than five nights has poor reliability 
(Acebo et al., 1999), suggesting some of the current data are unreliable. The sleep diaries 
were subjective in nature and often did not correspond to the data from the Actiwatches, it 
was unclear whether they had been filled in accurately and whether the sleep data is in fact 
valid. The results of the sleep data must therefore be interpreted with caution, making it 
difficult to draw robust conclusions about its association with memory. In future, creating a 
more simplistic diary and using memory aids, such as alarms, to remind participants to 
press the Actiwatch button may improve the accuracy of reporting. Including parent-
reports to corroborate information may also improve the reliability of the sleep data.  
 
A strength of the study is that it is the first to assess LTM after a delay longer than 30 
minutes in PBT survivors. The current study followed the learning paradigm described by 
Davidson et al. (2007), however they excluded children unable to reach learning criterion 
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after ten consecutive learning trials. The current study did not exclude these participants 
because this would have removed data from the most impaired individuals and would not 
have represented the sample, reducing the generalisability of results.  
 
The use of sibling and cousin controls minimised the environmental, parental and 
biological differences between groups. Paired analyses have more statistical power than 
independent-samples analyses (Lakens, 2013), somewhat improving the power of the study 
to detect differences. Groups were matched for age, IQ and socioeconomic status, 
controlling for potential effects of general cognitive ability and developmental differences 
between groups.  
 
The study tested each hypotheses with more than one statistical test, increasing the 
likelihood of finding a significant result by chance. Therefore a Bonferroni correction was 
applied to significant results or non-significant trends. It has been argued that effect sizes 
calculated for paired samples are overestimations of true effect sizes (Dunlap, Cortina, 
Vaslow & Burke, 1996), therefore reported effect sizes should be interpreted with caution. 
Due to the modest sample size and the data not meeting parametric assumptions, the 
association between variables was assessed using correlational analyses, which only 
assesses for strength of association. Future research could recruit larger samples by using a 
multi-centre design, which would allow a regression model to be used to further explore 
how much variability in memory is accounted for by different factors.  
 
Clinical and Educational Implications 
The results provide evidence that some PBT survivors have significant impairments in 
verbal learning and long-term visual and verbal retention, and others do not, confirming 
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the heterogeneous nature of the paediatric brain tumour population. These results suggest 
that learning and memory should be monitored in this population, but emphasises the 
importance of individual management plans. Schools should be aware that learning and 
retention can be impaired in PBT survivors who return to school following treatment, and 
that these individuals may require additional support. Three participants showed significant 
difficulty learning novel verbal information, which would likely have a substantial 
negative affect on their ability to secure meaningful employment, corroborated by the fact 
that these participants were unemployed. Studies of adult survivors also show that brain 
tumour survivors have difficulty securing and maintaining jobs (De Boer, Verbeek & Van 
Dijk, 2006), further indicating the need for support in this area. 
 
Intact memory in some PBT survivors may have been related to fewer risk factors; many 
PBT survivors only received surgery or focal radiotherapy, which are less damaging to the 
brain than whole-brain or cranio-spinal radiotherapy (Di Pinto et al., 2012). Although the 
study was small and future research is required to fully understand the relationship 
between different risk factors, the results from the current study are encouraging as they 
suggest not all PBT survivors experience memory difficulties post-treatment. This may 
give reassurance to young people and their families who post-diagnosis and may influence 
the choice of treatment in this group. 
 
The results regarding the association between memory and anxiety, depression and sleep 
variables were inconclusive and an association may exist. Therefore the screening of PBT 
survivors for sleep and psychological difficulties should still occur. As the scales used in 
the current study are quick and easy to administer, they would be appropriate tools for this.  
 
 
 
67 
 
Conclusions 
Results clearly demonstrated the variability in verbal learning and long-term verbal and 
visual retention in PBT survivors; some had significant impairments whilst others had 
none. This highlights the heterogeneity in the PBT population and the need for clinical 
monitoring to be conducted on a case-by-case basis. There was evidence of verbal learning 
impairment in PBT survivors relative to healthy controls, however, due to the modest 
sample size within the study, it was difficult to draw robust conclusions about the level of 
long-term memory impairment of PBT survivors as a group. As results suggest memory is 
not impaired in all PBT survivors, it may influence on clinical decisions regarding the 
choice of treatment for PBT. Within education and occupational settings, an awareness of 
the difficulties some of the young people may face could encourage services to give 
appropriate support to PBT survivors, to improve learning and secure meaningful 
employment. Results tentatively suggest memory consolidation may be impaired in PBT 
survivors, indicating the importance of longer delays to assess long-term memory in this 
population. This study will hopefully promote further high-quality, multi-centre research 
exploring the various risk and protective factors associated with memory in homogeneous 
PBT survivors.  
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Abstract 
A core competency for psychological therapists is the ability to engage clients using a 
range of skills to build and maintain active involvement of clients, communicate 
effectively with clients and respond to challenges in engagement (Core competence 
Framework for working in Child and Adolescent Mental Health Services; Roth, Calder and 
Pilling, 2011; 10 Essential Shared Capabilities for psychological therapies work, NHS 
Education for Scotland, 2011). Throughout the training programme, I have had a number 
of clients disengage with therapy and have found these unplanned endings difficult, 
affecting both my beliefs about myself and my confidence in my clinical skills. I have used 
the Kolb Experiential Learning Cycle (1984) to structure reflections about three clients 
whose disengagement I found particularly challenging and the Integrated Developmental 
Model of Supervision (Stoltenberg, McNeill, and Delworth, 1998) to contextualise each 
case in terms of my level of training and development. Not only have the experiences 
allowed me to develop clinically and learn how to better manage challenges in the future, 
but the reflective process facilitated my understanding and acceptance of myself and my 
limitations.  
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Abstract 
New legislation and government drivers have had an impact on the way mental health 
services are run. As a result, a range of professionals work together in mental health teams 
to provide effective and efficient services. The British Psychological Society (2007) 
suggest clinical psychologists should be involved in delivering consultation and 
supervision to other team members, to ensure evidence-based psychological interventions 
are being delivered effectively, and in service development, by taking on leadership and 
managerial roles. Throughout my training, I have had a number of experiences that have 
made me reflect on my role and contribution to team functioning, from which I have 
learned a lot. I have used the Integrated Developmental Model of Supervision (Stoltenberg, 
McNeill, and Delworth, 1998) to contextualise the development of my awareness of 
multidisciplinary team functioning and my contribution to team working throughout the 
training. I used the Reflective Cycle (Gibbs, 1988) to guide and structure reflections about 
specific experiences, such as my involvement in team activities, contributing to team 
supervision and sharing personal reflections, and being part of challenging team 
experiences. Through these reflections, I have learned the importance of being an 
integrated member of a team as well as my role, such as encouraging team working and 
decision-making, and facilitating the resolution of difficult team dynamics by encouraging 
reflection in team supervision. The reflection has also developed my awareness of the 
challenges that I may face in the future and how I will manage them in a constructive way.   
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printed version of the manuscript. Authors with questions concerning manuscript 
submission should address these directly to the Neuropsychology Editorial Office. 
In addition to addresses and phone numbers, please supply email addresses and fax 
numbers, if available, for potential use by the Editorial Office and later by the Production 
Office. Keep a copy of the manuscript to guard against loss. 
Neuropsychology is a bimonthly, peer-reviewed journal that typically publishes original 
research as full-length regular articles. A detailed description of the editorial coverage 
policy appears on the inside of the front cover of each issue. Other article formats — such 
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topics, or that evaluate competing theoretical perspectives on the basis of published data, 
may also be accepted. Comprehensive reviews of the empirical literature in an area of 
study are acceptable if they contain a meta-analysis and/or present novel theoretical or 
methodological perspectives. Please see the journal's Policy on Meta-Analyses (PDF, 
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manuscripts submitted by authors from non-English speaking countries. It is strongly 
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to the International System of Units (SI; see the Publication Manual). 
Statistical Considerations 
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APA guidelines for statistical methods and reporting, L. Wilkinson and the Task Force on 
Statistical Inference, 1999, "Statistical Methods in Psychology Journals: Guidelines and 
Explanations," American Psychologist, 54, 594–604 (PDF, 1171KB). 
Tables 
Each table should be submitted with the manuscript file. Each should start on a separate 
page and must be numbered and labeled with an appropriate title. All tables must be self-
explanatory. 
Masked Review 
Masked reviews are required. 
Each copy of a manuscript should include a separate title page with authors' names and 
affiliations, and these should not appear anywhere else on the manuscript. Footnotes that 
identify the authors should be typed on a separate page. 
It is the authors' responsibility to see that the manuscript itself contains no clues to their 
identities. Please ensure that the final version of your manuscript for production includes a 
byline and full author note for typesetting. 
Submission Letter 
Include the following in your submission letter: 
 a statement of compliance with APA ethical standards 
 a statement that the manuscript or data have not been published previously and that 
they are not under consideration for publication elsewhere 
 a statement to reflect that all listed authors have contributed significantly to the 
manuscript and consent to their names on the manuscript 
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Manuscript Acceptance 
Upon acceptance of their manuscript for publication, authors are expected to provide 
permissions, signed and dated copyright release and disclosure of interest forms, and a 
statement of compliance with APA ethical standards. 
Proofs 
All proofs must be corrected and returned within 48 hours of receipt. Any extensive 
nonessential changes and extensive changes due to author error may incur charges. 
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With the proofs will be a form providing the author with the opportunity to order reprints. 
Direct inquiries to the APA Journals Office can be made at 202-336-5540; fax 202-336-
5549. 
Manuscript Preparation 
Prepare manuscripts according to the Publication Manual of the American Psychological 
Association (6th edition). Manuscripts may be copyedited for bias-free language (see 
Chapter 3 of the Publication Manual). 
Double-space all copy. Other formatting instructions, as well as instructions on preparing 
tables, figures, references, metrics, and abstracts, appear in the Manual. Below are 
additional instructions regarding the preparation of display equations, computer code, and 
tables. 
Tables 
Use Word's Insert Table function when you create tables. Using spaces or tabs in your 
table will create problems when the table is typeset and may result in errors. Review APA's 
Checklist for Manuscript Submission before submitting your article. 
Submitting Supplemental Materials 
APA can place supplemental materials online, available via the published article in the 
PsycARTICLES® database. Please see Supplementing Your Article With Online Material 
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with parts labeled a, b, c, d, etc.) should be assembled into one file. 
The minimum line weight for line art is 0.5 point for optimal printing. For more 
information about acceptable resolutions, fonts, sizing, and other figure issues, please see 
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APA offers authors the option to publish their figures online in color without the costs 
associated with print publication of color figures. The same caption will appear on both the 
online (color) and print (black and white) versions. To ensure that the figure can be 
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For authors who prefer their figures to be published in color both in print and online, 
original color figures can be printed in color at the editor's and publisher's discretion 
provided the author agrees to pay: 
 $900 for one figure 
 An additional $600 for the second figure 
 An additional $450 for each subsequent figure 
Permissions 
Authors of accepted papers must obtain and provide to the editor on final acceptance all 
necessary permissions to reproduce in print and electronic form any copyrighted work, 
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On advice of counsel, APA may decline to publish any image whose copyright status is 
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Publication Policies 
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Guidelines. 
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reporting of research (e.g., financial interests in a test or procedure, funding by 
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Wellcome Trust or Research Councils UK Publication Rights Form (PDF, 34KB) 
Ethical Principles 
It is a violation of APA Ethical Principles to publish "as original data, data that have been 
previously published" (Standard 8.13). 
In addition, APA Ethical Principles specify that "after research results are published, 
psychologists do not withhold the data on which their conclusions are based from other 
competent professionals who seek to verify the substantive claims through reanalysis and 
who intend to use such data only for that purpose, provided that the confidentiality of the 
participants can be protected and unless legal rights concerning proprietary data preclude 
their release" (Standard 8.14). 
APA expects authors to adhere to these standards. Specifically, APA expects authors to 
have their data available throughout the editorial review process and for at least 5 years 
after the date of publication. 
Authors are required to state in writing that they have complied with APA ethical standards 
in the treatment of their sample, human or animal, or to describe the details of treatment. 
 Download Certification of Compliance With APA Ethical Principles Form (PDF, 
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Appendix 1.2 SIGN Methodology Checklist for Cohort Studies 
 
S I G N 
Methodology Checklist 3: Cohort studies 
Study identification  (Include author, title, year of publication, journal title, pages) 
Guideline topic:   Key Question No: Reviewer: 
Before completing this checklist, consider: 
1. Is the paper really a cohort study? If in doubt, check the study design algorithm available from 
SIGN and make sure you have the correct checklist. 
2. Is the paper relevant to key question? Analyse using PICO (Patient or Population Intervention 
Comparison Outcome). IF NO REJECT (give reason below). IF YES complete the checklist.. 
Reason for rejection: 1. Paper not relevant to key question □   2. Other reason □  (please specify): 
Please note that a retrospective study (ie a database or chart study) cannot be rated higher than +. 
SECTION 1:  INTERNAL VALIDITY 
In a well conducted cohort study: Does this study do it? 
i1.1 
 
The study addresses an appropriate and clearly focused question. Yes  □ 
Can’t say  
No □ 
 
SELECTION OF SUBJECTS 
ii1.2 The two groups being studied are selected from source 
populations that are comparable in all respects other than the 
factor under investigation. 
Yes  □ 
Can’t say □ 
No □ 
Does not 
apply □ 
iii1.3 The study indicates how many of the people asked to take part did 
so, in each of the groups being studied. 
 
Yes  □ 
 
No □ 
Does not 
apply □ 
iv1.4 The likelihood that some eligible subjects might have the outcome 
at the time of enrolment is assessed and taken into account in the 
analysis.  
Yes  □ 
Can’t say □ 
No □ 
Does not 
apply □ 
v1.5 What percentage of individuals or clusters recruited into each arm 
of the study dropped out before the study was completed. 
 
vi1.6 Comparison is made between full participants and those lost to 
follow up, by exposure status. 
Yes  □ 
Can’t say □ 
No □ 
Does not 
apply □ 
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ASSESSMENT 
vii1.7 The outcomes are clearly defined. Yes  □ 
Can’t say □ 
No □ 
 
viii1.8 The assessment of outcome is made blind to exposure status. If 
the study is retrospective this may not be applicable. 
Yes  □ 
Can’t say □ 
No □ 
Does not 
apply □ 
iv1.9 Where blinding was not possible, there is some recognition that 
knowledge of exposure status could have influenced the 
assessment of outcome. 
Yes  □ 
Can’t say □ 
No □ 
□ 
x1.10 The method of assessment of exposure is reliable.  Yes  □ 
Can’t say □ 
No □ 
 
xi1.11 Evidence from other sources is used to demonstrate that the 
method of outcome assessment is valid and reliable. 
Yes  □ 
Can’t say □ 
No □ 
Does not 
apply□ 
xii1.12 Exposure level or prognostic factor is assessed more than once. Yes  □ 
Can’t say □ 
No □ 
Does not 
apply □ 
CONFOUNDING 
xiii1.13 The main potential confounders are identified and taken into 
account in the design and analysis. 
Yes  □ 
Can’t say □ 
No □ 
 
STATISTICAL ANALYSIS 
xiv1.14 Have confidence intervals been provided? Yes  □ No □ 
SECTION 2:  OVERALL ASSESSMENT OF THE STUDY 
xv2.1 How well was the study done to minimise the risk of bias or 
confounding? 
 
High quality (++) □ 
Acceptable (+) □ 
Unacceptable – reject 0  
2.2 Taking into account clinical considerations, your evaluation of the 
methodology used, and the statistical power of the study, do you 
think there is clear evidence of an association between exposure 
and outcome? 
Yes   
Can’t say  
No  
 
2.3 Are the results of this study directly applicable to the patient group 
targeted in this guideline? 
Yes  □ No □ 
2.4 Notes. Summarise the authors conclusions. Add any comments on your own assessment 
of the study, and the extent to which it answers your question and mention any areas of 
uncertainty raised above. 
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Appendix 1.3 Summary of ratings for each item on SIGN Checklist.  
 
Questions from the adapted 
checklist for appraising 
methodology 
Conklin  
et al. 
(2012) 
Garcia-
Perez et 
al. 
(1994) 
Law et 
al. 
(2011) 
Mabbott 
et al. 
(2008) 
Ozyurt 
et al. 
(2014) 
Quintero-
Gallego et 
al. (2006) 
Redmond 
et al. 
(2013) 
Riva et 
al. 
(2002) 
Robinson  
et al. 
(2014) 
Shortman 
et al. 
(2014) 
1.1 The study addresses an 
appropriate and clearly 
focused question. 
Y Y Y Y Y Y Y Y Y Y 
1.2 The two groups being 
studied are selected from 
source populations that are 
comparable in all respects 
other than the factor under 
investigation. 
N 
 
Y  N 
 
Y  Y  
 
N  
 
N  
 
Y 
 
Y 
 
Y 
 
1.3 The study indicates how 
many of the people asked to 
take part did so, in each of the 
groups being studied. 
N N N Y N N N Y Y Y 
1.4 The likelihood that some 
eligible subjects might have 
the outcome at the time of 
enrolment is assessed and 
taken into account. 
N N N N N N N N N N 
1.5 What percentage of 
individuals or clusters 
recruited into each arm of the 
study dropped out before the 
study was completed. 
NA NA NA NA NA NA Y NA Y Y 
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(1994) 
Law et 
al. 
(2011) 
Mabbott 
et al. 
(2008) 
Ozyurt 
et al. 
(2014) 
Quintero-
Gallego et 
al. (2006) 
Redmond 
et al. 
(2013) 
Riva et 
al. 
(2002) 
Robinson  
et al. 
(2014) 
Shortman 
et al. 
(2014) 
1.6 Comparison is made 
between full participants and 
those lost to follow up. 
 
NA NA NA NA 
 
NA NA N NA N N 
1.7 The outcomes are clearly 
defined. 
Y Y Y Y Y Y Y Y Y Y 
1.8 The assessment of 
outcome is made blind to 
exposure status. If the study is 
retrospective this may not be 
applicable. 
N N N N N N N N N N 
1.9 Where blinding was not 
possible, there is some 
recognition that knowledge of 
exposure status could have 
influenced the assessment of 
outcome. 
N N N N N N N N N N 
1.10 The method of assess. of 
exposure is reliable. 
Y Y Y Y Y Y Y Y Y Y 
1.11 Evidence from other 
sources is used to demonstrate 
that the method of outcome 
assessment is valid and 
reliable. 
Y Y Y Y Y Y 
 
Y Y Y Y 
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Conklin  
et al. 
(2012) 
Garcia-
Perez et 
al. 
(1994) 
Law et 
al. 
(2011) 
Mabbott 
et al. 
(2008) 
Ozyurt 
et al. 
(2014) 
Quintero-
Gallego et 
al. (2006) 
Redmond 
et al. 
(2013) 
Riva et 
al. 
(2002) 
Robinson  
et al. 
(2014) 
Shortman 
et al. 
(2014) 
1.12 Exposure level or 
prognostic factor is assessed 
more than once. 
Y Y Y Y Y Y Y Y Y Y 
1.13 The main potential 
confounders are identified and 
taken into account in the 
design and analysis. 
N 
 
Y 
 
N 
 
Y 
 
Y 
 
N 
  
N 
 
Y 
 
Y  
 
Y 
 
1.14 Have confidence 
intervals been provided? 
 
N N N N N N N N Y N 
2.1 How well was the study 
done to minimise the risk of 
bias or confounding? 
+ ++ + + ++ + + ++ ++ ++ 
2.2 Taking into account 
clinical considerations, your 
evaluation of the 
methodology used, statistical 
power of the study, do you 
think there is clear evidence 
of an association between 
exposure and outcome? 
Can’t say Y Y N Y Can’t say Can’t say Y  
 
Y N 
2.3 Are the results of this 
study directly applicable to 
the patient group targeted in 
this guideline? 
Y Y Y Y Y Y Y Y Y Y 
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Appendix 2 
Appendix 2.1 Major Research Project Proposal 
 
Proposal for Memory After Tumour of the CNS in Childhood (MATCCh): Long-
Term Memory Retention in Paediatric Brain Tumour Survivors 
Abstract 
Background  
There is evidence that paediatric brain tumour survivors have impaired long-term memory 
(Benesch et al., 2009; Maddrey et al., 2005). Research has focussed on 30-minute memory 
retention, which may not be representative of everyday memory requirements. Anecdotal 
evidence from the literature suggests that brain tumour survivors have difficulties with 
memory retention and applying learned information (Waber et al., 2006; Ondrucht et al., 
2011), which suggests that learned information is vulnerable to loss. Sleep difficulties, 
anxiety and depression are frequently reported by brain tumour survivors, and may be 
exacerbating memory deficits.  
Aims  
The primary aim is to explore whether young people (11-24 years) who have survived a 
brain tumour show impaired learning, recall and recognition of verbal and non-verbal 
information compared to controls, at 30 minute and one week delays. A secondary aim is 
to explore to what extent sleep, anxiety and depression account for memory differences 
between survivors and controls. 
Methods 
An experimental learning paradigm, in which participants learn verbal and nonverbal 
information until an 80 % criterion, will be adopted. A prospective, within and between-
subjects design will be used to compare memory scores between brain tumour survivors 
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and healthy sibling controls, at two times points (30 minutes and 1 week). The extent to 
which Sleep Efficiency (measured by actigraphy), anxiety and depression (measured by 
self-report questionnaires) account for memory differences between the groups will also be 
analysed.  
Applications 
If there is evidence that brain tumour survivors have impaired long-term memory retention, 
it would support the use of memory-based interventions and additional school supports 
within this population. Results will build on existing knowledge of the psychological 
factors associated with neurocognitive functioning in this population. 
 
Introduction 
In the United Kingdom, 24.5 percent of all new cancer diagnoses in children below the age 
of 14 are due to central nervous system tumours (Stiller, 2007). The World Health 
Organisation Classification of Tumours of the Central Nervous System (Louis et al., 2007) 
classifies tumours based on their area and tissue of origin and grades tumour severity 
(Grades I to IV) based on the abnormality of cell growth. Higher grades suggest faster cell 
growth, worse prognosis and more intensive treatments. The most common diagnoses in 
young people are pilocytic astrocytoma, craniopharyngioma and medulloblastoma.   
 
The main treatments for brain tumour include neurosurgical resection, followed by 
chemotherapy and/or radiotherapy treatments. Survival rates in young people with brain 
tumours have improved drastically over the past twenty years, but evidence suggests both 
tumour and treatment factors can lead to long-term neurological damage (Di Pinto et al., 
2013). Tumours and surgical resection can damage healthy brain tissue, and chemotherapy 
and radiotherapy treatments can be neurotoxic to the brain (Turner et al., 2009). There is 
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evidence that chemotherapy and radiotherapy treatments damage the development of 
cortical and subcortical white matter in the brain, affecting neurocognitive function 
(Reddick et al., 2003). As full myelination is not complete until adulthood, children are 
particularly vulnerable to cognitive impairments if white matter is damaged or its growth is 
affected (Askins and Moore, 2008).  
 
Neurocognitive consequences 
The literature suggests children and young people who have been treated for a brain 
tumour experience a range of neurocognitive deficits, including overall cognitive ability, 
verbal memory and language (Robinson et al., 2010). Executive function, speed of 
processing and attention are also likely to be impaired following brain tumour (Gehrke et 
al., 2013), which control and moderate abilities in new learning and memory consolidation. 
In addition, children may miss years of school and ongoing interruptions during treatment 
which could further impact learning and memory.  
 
Memory  
The term memory is used to describe the process of encoding, consolidating and retrieving 
information and there is evidence that all three processes are impaired in paediatric brain 
tumour survivors (Waber et al., 2006 and Carpentieri et al., 2001). Research suggests 
paediatric brain tumour survivors have deficits in visual and verbal working memory 
(sometimes referred to as short-term memory) and long-term memory (LTM) compared to 
normative data and healthy controls (Bonner and Hardy, 2009; Maddrey et al., 2005), 
although there is some evidence that memory ability remains stable post-treatment (Di 
Pinto et al., 2012).  
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Standardised assessments measure LTM using 30 minute delayed recall tasks, which may 
not be representative of everyday memory requirements (Waber et al., 2006). Several 
studies include anecdotal evidence of participants reporting difficulties with everyday 
memory suggestive of consolidation and retention deficits (Carpentieri et al., 2011; Waber 
et al., 2006), and parents reporting their children having difficulty applying information 
they have learned (Ondrucht et al., 2011). Anecdotally, parents and teachers report that 
brain tumour survivors learn information to an adequate level, but retain less than expected 
compared to class peers the following week. This suggests new information that has been 
encoded to LTM is not retrieved effectively or it is vulnerable to loss over longer time 
periods in brain tumour survivors. As this would significantly impact learning, longer-term 
memory retention should be explored in this population.  
 
No studies have been identified that assess long-term memory over 30 minutes in brain 
tumours survivors, but studies of different paediatric neurological populations have 
adopted learning paradigms to determine the proportion of information recalled and 
recognised after much longer delays (usually one week). Davidson et al. (2007) taught 
children with idiopathic generalised epilepsy and healthy controls verbal and non-verbal 
information until they reached a learning criterion, and assessed memory retention after 30 
minutes and one week. Children with epilepsy recalled significantly less verbal 
information than controls after a week, suggesting ‘accelerated forgetting’, or that memory 
consolidation takes longer than 30 minutes. Similar evidence from adult epilepsy studies 
suggests it can be vulnerable to disruption for four weeks (Naryanan et al., 2012). It is 
unknown whether paediatric survivors of brain tumours are impaired in memory 
consolidation and retention over a week. If such impairments are found, it would support 
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the use of memory-based interventions and additional support in school, in order to 
improve academic, occupational and social functioning in this population.  
 
Factors influencing memory and learning 
Biological Factors 
Tumour and treatment   
Evidence for LTM deficits exists across a range of brain tumour diagnoses, although 
higher-grade tumours, medulloblastomas or ependymomas, are associated with 
significantly worse LTM outcomes than lower-grade ones, pylocytic astrocytomas 
(Benesch et al., 2009). There is evidence that memory is affected by tumour location; LTM 
retention was found to be significantly more impaired in supratentorial tumours (within the 
cerebrum) than infratentorial tumours (within the cerebellum; King et al., 2004). This 
difference was not sustained once verbal intellectual abilities and attention were controlled 
for, however (Micklewright et al., 2007), which suggests memory deficits are not location-
specific. The combination of both chemotherapy and cranial radiotherapy during treatment 
are associated with poorer neurocognitive outcomes (De Ruiter et al., 2013). Younger age 
at treatment and longer time since treatment are also associated with poorer cognitive 
outcomes (Mulhern et al., 2005), possibly because younger children are at an earlier 
developmental stage, so have to acquire new skills within the context of the brain tumour 
and potential damage to the brain.  
 
Psychological Factors 
Sleep 
Good sleep is crucial for memory consolidation (Maquet, 2001) but there is evidence that 
survivors of paediatric brain tumours experience sleep problems, including initiating and 
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maintaining sleep, hypersomnia and fatigue (Verberne et al., 2012). Impaired working 
memory was shown to be associated with poorer sleep quality and increased sleepiness in a 
sample of adult survivors of childhood cancer, after age, gender and the effects of 
treatment were controlled for (Clanton et al., 2011). Although no research into the 
association between sleep and memory retention in paediatric survivors was identified, 
sleep may exacerbate memory difficulties in this population, which would support the use 
of administering evidence-based sleep interventions to those that require it, in order to 
improve neurocognitive and academic outcomes. The extent to which sleep accounts for 
differences in memory scores between brain tumour survivors and controls will therefore 
be explored. 
 
Depression and Anxiety 
A review of the literature suggests depression and anxiety are associated with poor 
academic performance in children (Owens et al., 2012) and brain tumour survivors present 
with significantly higher levels of distress and depression than sibling controls (Zebrack et 
al., 2004). If anxiety and depression were found to account for some of the differences 
between memory between survivors and healthy young people, it would support the use of 
psychological interventions to improve anxiety and mood in order to increase learning and 
academic achievement.  
 
 
Aims and hypotheses  
Aims  
1. Learning and Encoding 
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Explore whether children and young people who have survived a brain tumour 
show impaired learning of verbal and non-verbal information compared to healthy 
controls. 
2. Recall and Recognition 
Explore whether recall and recognition of verbal and nonverbal information after a 
30 minute delay are impaired in brain tumour survivors compared to healthy 
controls.  
3. Memory Retention 
Explore whether recall and recognition of verbal and nonverbal information at one 
week delay are impaired in brain tumour survivors compared to healthy controls.  
4. Explore the extent to which sleep efficiency accounts for differences between the 
memory in brain tumour survivors and healthy sibling controls. 
5. Explore the extent to which anxiety and depression account for differences between 
the memory in brain tumour survivors and healthy sibling controls. 
 
Hypotheses  
6. Brain tumour survivors require significantly more trials to learn verbal and non-
verbal information.  
7. Brain tumour survivors have significantly lower recall after 30 minutes delay than 
healthy controls. 
8. Brain tumour survivors have significantly lower recall at one week delay than 
healthy controls. 
9. Sleep efficiency (measured by actigraphy) will account for some of the memory 
differences between brain tumour survivors and healthy controls. 
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10. Depression and anxiety scores will account for some of the memory differences 
between brain tumour survivors and healthy controls.  
 
Plan of Investigation 
Design  
Experimental learning paradigm with a prospective, within and between-subjects design 
comparing 30 minute and 1 week delayed recall on a verbal and nonverbal task between 
brain tumour survivors and healthy age-matched sibling controls.  There is evidence to 
suggest several factors impact on neurocognitive functioning in brain tumour survivors, 
such as age at diagnosis, severity of tumour, treatment received and location of tumour. 
Due to the size of the proposed study, these factors will not be controlled for, but, in line 
with previous research, tumour and treatment factors will be fully described. Recruitment 
will also be conducted in a systematic way, recruiting participants with one tumour 
diagnosis first, and then expanding to the other diagnoses if participants numbers are not 
met. The main tumour diagnoses that will be included will be Medulloblastoma, Pilocytic 
Astrocytoma and Craniopharyngioma.  
 
Participants  
Participants will include young people who have survived any type of brain tumour 
between the ages of 11, the age they enter secondary school, and 24, the age they receive 
clinical reviews until.  The control group will consist of healthy siblings, cousins or best 
friends. Sumpter et al. (2013) chose sibling controls in recent sleep study, in order to match 
psychosocial, family and sleep environmental factors. If the brain tumour survivor is an 
only child or their sibling is much older/younger, relatives or best friends will be asked to 
participate as controls. They will be recruited via the brain tumour survivors or their 
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parents, who will gain their consent to pass on contact details to the researcher, who will 
contact them to organise participation.  
 
Inclusion and Exclusion Criteria  
Inclusion and exclusion criteria for sample of children who have survived a brain tumour: 
 Not undergoing chemotherapy or radiotherapy  
 Over 6 months since chemotherapy or radiotherapy were completed 
 Aged between 11 and 24 years 
 Fluent in English in order to complete verbal memory assessments 
 
Inclusion and exclusion criteria for healthy controls: 
 No history of cancer 
 No developmental disorders or disabilities eg: Autism Spectrum Disorder. 
 No history of neurological diagnoses (including head injury, brain tumour, 
neurological infection). 
 Not receiving treatment for a mental health disorder 
 No admission to hospital in the past 6 months 
 
Measures 
Intellectual Functioning 
Wechsler Abbreviated Scale of Intelligence- Second Edition (WASI-II; Wechsler, 2011) 
Estimates full-scale IQ using Matrix Reasoning and Vocabulary Subtests. Standardised for 
6-90 years. 
Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV; Weschler, 2011). 
Digit Span subtest as an estimate of working memory for participants under 16 years.  
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Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; Weschler, 2011). 
Digit Span subtest as an estimate of working memory for participants 16 years and over.  
 
Assessment of Memory  
Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996).  
Measure of auditory verbal memory which includes a list of 15 words. Good sensitivity 
and normed for ages 7 to 89. 
 
Rey Complex Figure Test (RCFT; Meyers &Meyers, 1996).  
Measure of visuo-spatial memory in which participants have to remember a design. It is 
normed for ages 7-89 and been used in previous research with paediatric populations 
(Micklewright et al., 2007). 
 
Anxiety and Depression 
The Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983). 
Although normed with an adult population, it has been validated in a sample of children 
aged between 12 and 17 by White et al. (1999). There was evidence to suggest the HADS 
has good test-retest reliability and can discriminate between adolescents with and without 
diagnoses of anxiety or depressive disorders.   
 
Sleep 
Actigraphy  
This in an objective measure of activity during sleep, which correlates with sleep 
efficiency. It will be worn by participants on non-dominant wrists every night for one week 
between the first and second appointments. 
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Sleep Self-Report (SSR; Owens et al., 2000) 
A retrospective, self-rated measure of sleep habits, problems falling asleep, sleep duration, 
night waking and daytime sleepiness. It includes 18 questions and shows good 
psychometric properties. It is validated for children between 7 and 12 years, however 
Sumpter et al. (2013) used this measure with adolescents over the age of 12 successfully.  
 
Sleep Diary 
Participants report when they go to bed, when the lights go off, when they fall asleep, 
when they rise and any daytime naps during the week of actigraphy. 
 
Fatigue Scale-Adolescent (Hinds et al., 2007)  
A 14 item self-report measure for fatigue for 13 to 18 year olds. Shows moderate to strong 
reliability and strong validity when compared to other instruments (Hinds et al., 2007). 
 
Sample size analysis 
In order to guide recruitment, an a priori sample size calculation was conducted based on 
the study by Narayanan et al. (2012). They found significant differences between 15 adults 
with epilepsy and 17 controls on their memory performance measured by the RAVLT at a 
4 week delay (epilepsy group: M= 3.71 (SD= 2.92); control group: M= 6.47 (SD= 2.48)).  
Assuming alpha equals 0.05 and beta equals 0.80, a sample size of 17 in each group would 
be necessary to find a significant difference on the RAVLT at a 4 week delay. Considering 
Narayanan et al. (2012) used an adult population and a longer delay than the proposed 
study, a larger sample size of 20 in each group would be an appropriate target for 
recruitment.  
 
 
102 
 
 
Research and Recruitment Procedures 
Approval from NHS Lanarkshire and Lothian R&D and NHS Ethics will be sought before 
recruitment is commenced. Children who have undergone treatment for a brain tumour in 
the Royal Hospital for Sick Children (RHSC) in Edinburgh and their families will be 
recruited. Information about these cases will be gathered through the Oncology service. 
The Oncology Research Nurse, Rachel McAndrew, involved in patient care at the RHSC 
in Edinburgh will recruit participants. She will send information to and invite young people 
and families to participate by post. Potential participants will telephone or email either 
Rachel McAndrew or the Principle Investigator, or send back a stamped addressed card 
indicating whether they consent to being contacted by the Principle Investigator. Families 
who consent, will be contacted by telephone at which time they will complete initial 
screening, be fully informed about the research and organise who the control will be (if it 
is a relative or best friend, the brain tumour survivor or their parents will be asked to 
recruit the control). Both the brain tumour survivors and their relative/best friend will then 
be invited to attend two data collection sessions (one week apart).  
 
The initial session last 1 hour for each child and be conducted in an outpatient hospital 
setting. Where possible, it will coincide with participants’ review appointments at hospital 
(every 3-12 months).  Participants below the age of 16 and their parents will be asked to 
sign a consent form, and young people below 12 will be asked to sign an assent form. 
Participants will complete the HADS before being administered the two-subtest version of 
the WASI-II and the Digit Span subtest of the WISC-IV or WAIS-IV (depending on the 
participant's age). Participants will then be taught the RAVLT and RCFT. The number of 
trials required for them to reach learning criterion, and immediate and 30-minute delayed 
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recall and recognition will be measured. Participants (and parents if under 16 years) will be 
given information on Actigraphy and how to use the Actiwatches, which all participants 
will wear for one week. Sleep diaries will also be completed during the week. Families will 
then be invited to another follow-up session after one week which will last 30 minutes, 
either at the hospital or at the family’s local health centre if they have difficulty travelling 
to Edinburgh. Parents/participants will return the Actiwatches and be asked to fill in the 
sleep and fatigue measures and be assessed on their retention of both memory tasks. The 
researcher will aim to collect data between October 2014 and May 2015 in order to attain 
the necessary sample size.  
 
The researcher will also attend team meetings and present the research at the hospital to 
increase staff awareness of the study, and clinicians will discuss the research with patients 
within review sessions to aid recruitment. A poster will be on display in the waiting areas 
to encourage participation and provide information. Neuro-Oncology clinicians will be 
available to answer questions regarding the study.  
 
 
Data Analysis  
A repeated-measures Analysis of Variance (ANOVA) will be used to analyse the 
difference in memory retention between 30 minute and one week delays, and between 
brain tumour survivors and healthy sibling controls. Anxiety, depression and sleep scores 
will be used as  covariates against memory between the two groups, and an ANCOVA will 
be used to analyse the extent to which the covariates account for memory differences 
between brain tumour survivors and controls.  
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Settings and Equipment  
All testing will be done by the researcher either at the RHSC, the Western General 
Hospital or in local health centres throughout Scotland. The neurocognitive measures 
(WASI-II, WISC-IV, RAVLT and RCFT) and Actiwatches are available within from the 
University of Glasgow. All other measures are not copyrighted and available from the 
internet.  
 
Financial Issues  
The neurocognitive assessment measures (WASI-II, WISC-IV, WAIS-IV, RAVLT and 
RCFT) are copyrighted and therefore 50 score sheets will have to be purchased for the 
study; printing and mail costs are also required, all funded by the University of Glasgow. 
Travel expenses will be claimed back from NES through NHS Lanarkshire. 
 
Health and Safety Issues  
Researcher and Participant Safety Issues  
If the researcher has to travel to different health centres independently, lone working 
policies for NHS Lothian will be followed and a mobile telephone and personal alarm will 
be carried at all times. The assessments are brief, standardised on large populations, 
regularly used with clinically impaired populations and generally well accepted by children 
and adults.  If a participant is becomes fatigued or anxious, a break will be given and the 
participant will be provided with any appropriate support by the researcher (a Trainee 
Clinical Psychologist with significant experience in emotional distress and administering 
neuropsychological assessments). Participants will be reminded of their right to withdraw 
at any stage if it is felt appropriate.  
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Ethical Issues 
Due to the vulnerable nature of the sample, written informed consent from young people 
and also their parents if they are below 16. If a participant is becomes fatigued or 
distressed, a break will be given and the participant will be provided with any appropriate 
support by the Principle Investigator (a Trainee Clinical Psychologist in the final year of 
training with significant clinical experience in administering neuropsychological 
assessments and in treating emotional disorders). If participants show elevated levels of 
anxiety or depression in their questionnaires, they will discussed with the Field Supervisor, 
Dr Ruth Sumpter, Clinical Psychologist in the Paediatric Psychology and Liaison Service 
at the Royal Hospital for Sick Children. Any appropriate onward referrals will be made to 
support or mental health services and a letter sent to their General Practitioner. All 
feedback about memory impairments will be given to participants in a sensitive way, to 
avoid them becoming upset.  
Assessment sessions will be arranged on the same days as clinical reviews as far as 
possible, and second appointments will be offered locally to families who live far from the 
hospital, in order to minimise the family's travelling time and costs. Actiwatches must be 
worn every day and night within the week between the assessment sessions. They are well 
tolerated by children for week-long use and are similar to wearing a wrist watch. 
Participants will be given a report regarding their memory, sleep, anxiety and depression, 
and appropriate referrals will be discussed with Dr. Ruth Sumpter (Clinical Psychologist in 
Paediatric Psychology and Liaison Service). Participants will be given information about 
their right to withdraw at any stage without it affecting the care they receive. Ethical 
approval will be sought from NHS Lothian Ethics committee.  Participants’ General 
Practitioners will be sent a letter notifying them of their participation in the study.  
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Timetable 
October 2014: Ethical approval 
November 2014: Begin recruiting and data collection 
May 2015: Finish data collection 
 
Practical Applications 
If the results suggest children who have survived a brain tumour have impaired retention of 
long-term memory, it would suggest that this population is vulnerable to academic and 
possibly social difficulties and would support the use of memory-based interventions and 
additional support in school within this population.  It will also build on existing 
knowledge of the psychological factors associated with neurocognitive functioning in this 
population.  
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Appendix 2.5 Sleep Diary  
  Sleep Diary            Name:  
 
        
 Time you got 
in bed 
Time you 
turned out 
the lights 
Time when 
you fell asleep 
Times you 
were awake 
during the 
night 
 Time your 
alarm went 
off 
Time you got 
out of bed 
Times you 
were asleep 
during the 
day (naps) 
Notes 
(did you take 
the actiwatch 
off?) 
Friday night     Saturday 
Morning 
    
Saturday 
Night 
    Sunday 
Morning 
    
Sunday Night     Monday 
Morning 
    
Monday Night     Tuesday 
Morning 
    
Tuesday 
Night 
    Wednesday 
Morning 
    
Wednesday 
Night 
    Thursday 
Morning 
    
Thursday 
Night 
    Friday 
Morning 
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Appendix 2.7 Further Analyses on Sleep and Psychological Factors 
Table 1. Results for Sleep and Psychological Factors 
Measure  Tumour Group 
*Mean (SD) 
Median (IQR) 
n Control Group 
Mean (SD) 
Median (IQR) 
n n in 
analysis 
HADS Depression 
 
4 (1.25) 10 1 (3) 10 20 
 Anxiety 
 
8 (4.76)* 10 4 (2.26)* 10 20 
AFS Total Fatigue 
Score 
 
27 (5.31)* 10 18.44 (2.83)* 9 18 
SSR Total Sleep 
Problems 
Score 
 
33 (5) 10 30 (4.5) 9 18 
Actigraphy Sleep 
Efficiency 
(Percentage) 
78.59 (7.57) 10 77.44 (6.84) 9 18 
 Sleep Latency 
(Minutes) 
15.85 (35.66) 10 21.0 (19.03) 9 18 
 Percentage of 
Immobile 
Minutes 
86.74 (5.71) 10 84.60 (8.00) 9 18 
 Fragmentation 
Index 
24.12 (17.81) 10 33.70 (20.05) 9 18 
Key 
AFS= Adolescent Fatigue Scale 
HADS= Hospital Anxiety and Depression Scale 
SD= Standard Deviation  
SSR= Sleep Self-Report 
 
 
There were no significant group differences in sleep efficiency (Wilcoxon Signed Rank 
Test (WSRT); W=16, Z= -0.770, p=0.441, effect size 0.18). Sleep latency (WSRT; W=23, 
Z=0.059, p=0.953, effect size 
 -0.01), percentage of immobile sleep (WSRT; W= 18.0, Z= -0.533, p= 0.594, effect size 
0.13) and the Fragmentation Index (an indication of greater restlessness in sleep; WSRT; 
W=31, Z=1.007, p=0.314, effect size -0.24) did not differ significantly between groups. 
There was a trend for higher self-reported sleep problems in the tumour compared to the 
control group (WSRT; W=3.5, Z= -1.781, p=0.075; effect size 0.42). The tumour group 
reported total sleep disturbance scores that were more than four, and the control group 
reported mean scores more than three standard deviations above reported normative data in 
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healthy children (Owens, Maxim, Nobile, McGuinn & Msall, 2000). The tumour group 
reported significantly higher fatigue than the control group (paired samples t-test; t=4.272, 
df= 8, p=0.003, d=2.01).  The mean score in the tumour group was below the cut-off of 31 
suggested by Mandrell et al. (2011) to identify high fatigue in adolescents receiving 
treatment for cancer. As all participants in the current sample had completed treatment at 
least six months before assessment, lower scores would be expected.   
 
Objective sleep quality did not differ significantly between groups and there was a non-
significant trend for higher self-reported sleep disturbance in the tumour group. Both 
groups had mean sleep efficiency scores indicative of poor sleep quality (based on the 85 
percent level used in the literature; Astill et al., 2013). Half of the control sample were not 
in full-time employment/education or were on leave during the week of assessment, which 
may have affected their lifestyle and daily routine, and as a result their sleep quality. The 
groups are comparable in terms of psychosocial background, socioeconomic status and 
numbers not in full-time employment or study, but other lifestyle factors that may affect 
sleep were not controlled for and may have influenced results. Actigraphy data must also 
be interpreted with caution as adherence to the wearing the Actiwatches and filling in the 
sleep diaries was generally poor within the sample, questioning the validity of the data.  
 
Self-report of fatigue was significantly higher in survivors, suggesting they experience 
greater daytime fatigue and physical tiredness, and require more rest than matched 
controls. Survivors reported significantly higher depression and anxiety than controls, 
although mean scores were within the normal range, suggesting that overall, the sample did 
not have significant psychological difficulties associated with having a brain tumour. The 
sample comprised survivors who had completed treatment at least two years before, which 
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may have been sufficient time to process some of the emotional impact of cancer diagnosis 
and treatment.  
 
There is evidence of greater self-reported fatigue and disorders of excessive somnolence 
and of initiating and maintaining sleep in paediatric brain tumour survivors relative to 
normed data (Verberne, Maurice-Stan, Grootenhuis, Van Santen & Schouten-Van 
Meeteren, 2012). Current findings were consistent with this. Both tumour and control 
groups reported greater sleep disturbance (on Sleep Self-Report) than data from previous 
research with healthy children (Owens, Maxim, Nobile, McGuinn & Msall, 2000; Hinds et 
al., 2007). Recent research using the Sleep Self-Report to assess sleep in adolescents with 
Inflammatory Bowel Disease (IBD) reported a mean total score of 36.4 (standard deviation 
4.3) for the mild IBD group, and although values were not reported for healthy controls, 
mean scores did not differ significantly (Pirinen, Kolho, Simola, Ashorn &Aronen, 2010). 
This suggests that adolescents may report more disturbed sleep than younger children. 
Melatonin is a hormone that regulates sleep; during puberty there is a decrease in the 
amount produced by the body (Carskadon, Vieira & Acebo, 1993), which affects sleep 
cycles in adolescence. As the current sample comprised adolescents, the described changes 
during puberty may have contributed to the poor sleep quality reported by both the tumour 
and the control groups. 
 
Previous studies assessing sleep with Actigraphy found no differences between paediatric 
brain tumour survivors and age-matched healthy controls (Greenefield, Constantini, 
Tauman & Sivan, 2011), consistent with current findings. Both groups had mean sleep 
efficiency values that indicate poor sleep if using the 85 percent cut-off. This may reflect 
general sleep difficulties in adolescence and suggests no further treatment or tumour 
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factors affect sleep quality. Recent research assessing sleep in healthy adolescents reported 
mean sleep efficiency values of 81 percent (Astill et al., 2013), suggesting previous cut-
offs suggested for adults may not be valid with this age group, although further research is 
warranted.  
 
The tumour group reported significantly higher anxiety (paired-samples t-test; t=2.362, 
df=9, p=0.042 d=1.07) and depression (WSRT; W=1, Z= -2.205, p=0.027, effect size 0.49) 
than the control group, although mean scores fell within the normal range for both scales.  
 
Higher Digit Span scores were associated with better recall after 30 minutes on the 
RAVLT (rho=0.693, p=0.026), suggesting that verbal working memory and long-term 
memory encoding and/or recall are related. In terms of sleep and psychological factors, 
higher self-reports of depression were associated with higher self-reports of anxiety (rho= 
0.656, p=0.039) and a higher percentage of time in ‘immobile sleep’ (rho= 0.646, 
p=0.044). Better sleep efficiency was related to a higher percentage of time in ‘immobile 
sleep’ (rho= 0.661, p=0.038), and lower values for the Fragmentation Index (lower values 
indicating less restlessness in sleep) were associated with both better sleep efficiency (rho= 
-0.736, p=0.015) and a higher percentage of time in ‘immobile sleep’ (rho= -0.839, 
p=0.002). The associations between psychological and sleep variables were expected; there 
is high co-morbidity between anxiety and depression in the paediatric population (Garber 
and Weersing, 2010) and depression is related to increased deep, immobile sleep in 
adolescents (Rao & Poland, 2008). 
 
